Selbstmörderischer Erythrozytentod in der Malaria by Koka, Sai Sudha
 
 
 
Selbstmörderischer Erythrozytentod in der Malaria 
 
 
Suicidal Erythrocyte Death in Malaria 
 
 
DISSERTATION 
 
der Fakultät für Chemie und Pharmazie 
der Eberhard-Karls-Universität Tübingen 
 
zur Erlangung des Grades eines Doktors 
der Naturwissenschaften 
 
2008 
 
vorgelegt von 
Sai Sudha Koka 
  
 
 
 
 
 
 
 
 
 
 
 
 
Tag der mündlichen Prüfung:                                   27.02.2008 
Dekan:                                                                       Prof. Dr. L. Wesemann 
1. Berichterstatter:                                                     Prof. Dr. F. Lang 
2. Berichterstatter:                                                     Prof. Dr. P. Ruth 
 
ACKNOWLEDGEMENTS 
 
 
It is with immense pleasure, I record my humble gratitude to my research guide Prof. 
Dr. Florian Lang, for his expert guidance and critical review throughout the work. My 
sincere and heart felt thanks for his abundant encouragement. 
I am very grateful to PD Dr. Stephan Huber for his timely help, support, thought 
provoking suggestions and stimulating discussions during the progress of the work. I would 
like to thank Prof. Dr. Peter Ruth for giving me an opportunity to present the dissertation at 
the Faculty of Pharmacy and Chemistry, Eberhard Karls Universität Tübingen, Germany. 
My heart felt thanks to my colleague Dr. Camelia lang for her help and  assistance in 
organising the lab work. Her friendliness, patience made our lab an exciting place for me to 
work 
I am very thankful to my colleagues Dr. Christophe Duranton, Dr. Valerie Tanneur, 
Dr. Verena Brand, Dr. Ravi Sankar Kasinathan, Dr. Michael Föller, Mr Diwakar Bobbala 
for their help, suggestions and support. I also thank my friends and colleagues Ms.Ying, 
Ms. Teresa Ackermann, Mrs. Efi faber, Mr. Farooq, Mr. Uwe Schueler and Mr. Peter for 
their support and friendship. 
This task never completes without the mention of my loving parents Late. Mr.        
K. Balakrishna, Mrs. K. Rukmini and my brother Mr. K. Siva Anand and sister Mrs. Aparna 
who have blessed me in every aspect of my life. 
I dedicate my thesis to my beloved husband Dr. Krishna M. Boini for being a 
constant source of inspiration for my work. I am greatly indebted for his support, 
constructive criticism, prayers and endless love in my life.  
 
 
 
 
 
 
CONTENTS 
 
ABBREVIATIONS………………………………………………………………………...1  
 
SUMMARY    ……………………………………………………………………………...3 
 
ZUSAMMENFASSUNG........……………………………………………………………...6  
 
I. INRODUCTION…………………………………………………………………………9 
I. Malaria 
 I. 1. History, transmission and life Cycle of the malaria parasite ………………………….....10 
     I. 1.1 History     ................................................................................................................10 
     I. 1.2 Transmission of  malaria  .......................................................................................10 
     I. 1.3. Life Cycle of Plasmodium  ....................................................................................10 
I. 2. Invasion into the erythrocyte ..................................…………………..……………….13 
I. 3. Clinical manifestation and treatment of malaria .……………………….......................13 
I. 4. Erythrocyte cell death ………….………...……………………………………………..14 
    I. 4.1. Apoptosis of nucleated cells ..……………………………………….....................14 
    I. 4.2. Apoptosis of erythrocytes  ...................………………………................………...15 
    I. 4. 3. Mechanisms of erythrocyte cell death   .....................……………………...….....16 
    I. 4. 4. Physiological significance of eryptosis   ...............................................................19 
 I. 4. 5. Plasmodium infected erythrocytes ……………..………......................................20 
 I. 4. 6. Eryptosis in malaria…………….. ……………..……….......................................21 
I. 5. Rodent malaria parasites as models for human malaria.....………………….…...........22 
I. 6. Pathophysiological and pharmacological modification of eryptosis. …….….…......... 23         
    I. 6. 1. Influence of iron deficiency on course of malaria in P.berghei infected mice …  23 
    I. 6. 2. Impact of NO synthase inhibitor L-NAME on the course of malaria ………...... 24 
    I. 6. 3. Influence of lead treatment on P. berghei infected mice ……………………..... 25 
    I. 6. 4. Influence of chlorpromazine on the course of malaria………………………...... 26 
 
II. AIM OF THE STUDY......…………………………………………………….……….28 
 
III. METHODS……………………………………………………………………………29 
 
III. 1. Animals ………………………………………………………………………….…..29 
III. 2. Preaparation of human and mouse erythrocytes: …………………………………….....29 
III. 3. In vitro culture of  Plasmodium falciparum infected human erythrocytes: …………30 
III. 4. Freezing and defreezing of parasites ...........................................................................30 
III. 5. Isoosmotic sorbital synchronization of Plasmodium falcifarum infected human      
         erythrocytes:.............................................................................................................….......31 
III. 6. In vitro Plasmodium falciparum growth assay:…………………………….…..........31 
III. 7. Intraerythrocytic DNA amplification of P. falciparum……………………………...32 
III. 8. In vivo proliferation of Plasmodium falciparum ANKA ……....................................32 
III. 9. Fluorescence staining and flourescence microscopy ………..................................…..32 
III.10. Determination of phosphatidylserine exposure and forward scatter….……..…........33 
III.11. Determination of intracellular Ca2+  influx in the erythrocytes .………...........……. 33 
III.12. Measurement of the in vivo clearance of  erythrocytes in peripheral blood…...........34 
III.13. Measurement of the fluorescence-labelled erythrocytes in the spleens of mice........34 
III.14. Analysis of blood cell numbers .................................................................................34  
III.15. Analysis of mouse reticulocyte numbers ...................................................................35 
III.16. Data analysis and statistics ...............................................................................................35 
 
IV. RESULTS     …………………………………………………………………………..36                  
 
IV. 1. Influence of iron deficiency on the course of malaria in P. berghei infected mice 
IV. 1. 1 Annexin Binding of noninfected and infected erythrocytes of control and iron      
deficient patients .......................................................................................….............36 
IV. 1. 2  Intra erythrocytic DNA amplification.................................................................................36 
IV. 1. 3 In vitro growth of P. falciparum in erythrocytes of control and iron deficient           
patients ..................................... .................................................................................36 
IV. 1. 4 Forward scatter of control and iron deficient erythrocytes ...........................................39 
IV. 1. 5 In vivo clearance fluorescence labelled erythrocytes ....................................................39 
IV. 1. 6 In vivo proliferation of P.berghei in control and iron deficient mice  .....................42  
IV. 1. 7 Haematological parameters .....................................................................................44  
 
IV. 2. Impact of NO synthase inhibitor L-NAME on the course of malaria 
IV. 2. 1 Annexin binding of noninfected and infected erythrocytes of control and L-NAME  
             treated erythrocytes ..............................................................................………….…....45 
IV. 2. 2 In vitro growth of  P. falciparum in erythrocytes of control and L-NAME treated  
              erythrocytes ..............................................................................................................45 
IV. 2. 3 Forward scatter of  control and L-NAME treated erythrocytes ....................................48 
IV. 2. 4 In vivo clearance fluorescence labelled erythrocytes ....................................................49 
IV. 2. 5 In vivo proliferation of P. berghei in control and L-NAME treated mice ...............51 
 
IV. 3. Influence of lead treatment on P. berghei infected mice 
IV. 3. 1 Annexin binding of noninfected and infected erythrocytes of control and lead treated  
              Erythrocytes ...................................................................................................................53  
 
IV. 3. 2 Fluorescence staining and flourescence microscopy......................................................53 
 
IV. 3. 3 Forward scatter of control and lead treated erythrocytes ..............................................55 
 
IV. 3. 4 Intracellular Ca2+  influx in control and lead treated erythrocytes ............................56  
 
IV. 3. 5 In vitro growth of P. falciparum in erythrocytes of control and lead treated 
erythrocytes ................................................................................................................57 
IV. 3. 6 In vivo clearance of fluorescence labelled erythrocytes.................................................58 
IV. 3. 7 In vivo proliferation of P. berghei in control and lead treated mice ........................59 
IV. 3. 8 Haematological parameters .....................................................................................61 
 
IV. 4. Influence of chlorpromazine on the course of malaria 
IV. 4. 1 Annexin binding of noninfected and infected erythrocytes of control and   
              chlorpromazine treated erythrocytes .............................................................................62 
IV. 4. 2 In vitro growth of P. falciparum in erythrocytes of control and chlorpromazine       
treated erythrocytes .................................................................................................62 
IV. 4. 3 Forward scatter of control and chlorpromazine treated erythrocytes ...........................65 
 
IV. 4. 4 Clearance of chlorpromazine treated erythrocytes from circulating blood ..............66 
 
IV. 4.5 In vivo proliferation of P. berghei in control and chlorpromazine treated mice ......68 
V.   DISCUSSION..……………………………………………………………………….70                 
V. 1. Influence of iron deficiency on the course of malaria in P. berghei infected mice...…70      
V. 2. Impact of NO synthase inhibitor L-NAME on the course of malaria…… ………......72 
V. 3. Influence of lead treatment on P. berghei infected mice ………………….................73 
V. 4. Influence of chlorpromazine on the course of malaria……………………… ............74 
V. 5. Conclusions…………………………………………………………..……….............75 
 
VI. REFERENCES …………………………………………………………………..…..76 
 
VII. PUBLICATIONS OBTAINED DURING Ph.D WORK ………………..………..93 
 
VIII. AKADEMISCHE LEHRER....…..........……………………..……………….……..95 
 
IX. LEBENSLAUF ………………………………………………..……………….……..96 
 
ABBREVIATIONS 
 
AA   Arachidonic acid 
AIF   Apoptosis inducing factor  
ANOVA  Analysis of Variance between groups 
ATP   Adenosine 5´ triphosphate 
Ca2+   Calcium ion 
CaCl2   Calcium chloride 
CFSE   5,6-carboxylfluorescein diacetate succinimidyl ester 
Cl-   Chloride ion 
CO2   Carbon dioxide 
COX   Cyclooxygenase 
CSP                          Circum sporozoite protein 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
EIPA                          5-(N-ethyl-N-isopropyl) amiloride 
FACS   Fluorescence activated cell sorter 
FL-1   Florescence channel 1 
FSC   Forward scatter 
g   gram 
G6PD                         Glucose-6-phosphate dehydrogenase 
Gardos channel     Calcium activated potassium channel 
GSH                           Glutathione 
h   Hour 
Hb                              Hemoglobin 
HEPES             4-2-hydroxyethyl-1-piperazineethanesulfonic acid 
K+              Potassium ion 
KCl                             Potassium chloride 
L-NAME   Nω-Nitro-L-arginine methyl ester  
MCV   Mean corpuscular volume 
mg   Milligram 
MgSO4  Magnesium sulphate 
 1 
min   Minute 
ml   Milliliter 
mM   Millimolar (mmol/L) 
MSP                           Merozoite surface protein 
Na+   Sodium ion 
NaCl   Sodium chloride 
NaOH   Sodium hydroxide 
nM   Nanomolar 
NO3   Nitrate 
NPP   New Permeability Pathways 
NSC   Nonselective Cation Channel 
PAF   Platelet activating factor 
Pb (NO3)2  Lead nitrate 
PBS                   Phosphate buffered saline 
PCD   Programmed cell death 
PGE2    Prostaglandin E2 
PLA2    Phospholipase A2 
ppm                          Parts per million 
PS   Phosphatidylserine 
RBCs   Red Blood Cells 
RNA                            Ribonucleic acid 
RPMI   Roswell Park Memorial Institute 
RTC                            Reticulocytes 
SEM   Standard error mean 
TNF   Tumor necrosis factor 
TRAP   Thrombospondin-related adhesive protein 
µM   Micromolar 
WBC   White blood cells    
 
 
 
 
 2 
SUMMARY 
 
Malaria is one of the most devastating diseases with lethal outcome in more than 1 
million humans per year. The course of the disease is not only a function of the pathogen but 
is heavily influenced by properties of the host. Mechanisms possibly conferring protection 
against a severe course of malaria include suicidal death of the infected cell. A particular 
form of suicidal erythrocyte death is eryptosis, which is characterized by Ca2+-entry with 
subsequent activation of Ca2+-sensitive K+ channels, KCl exit and erythrocyte shrinkage, 
Ca2+-sensitive scrambling of phospholipids resulting in the breakdown of cell membrane 
phosphatidylserine asymmetry and phosphatidylserine exposure at the cell surface, as well 
as Ca2+ dependent activation of calpain, proteolytic degradation of cytoskeletal proteins 
and cell membrane blebbing. Eryptosis is triggered by different well-known pro apoptotic 
stressors, namely hyperosmotic shock, oxidative stress and energy depletion, which all 
activate Ca2+ -permeable nonselective cation channels allowing Ca2+ entry into the 
erythrocyte. Eryptosis is enhanced in several inherited erythrocyte disorders such as, 
phosphate depletion, hemolytic uremic syndrome, sepsis, and Wilson disease. As 
macrophages are equipped with receptors specific for phosphatidylserine, cells exposing 
phosphatidylserine at their surface will be rapidly recognized, engulfed, degraded and thus 
cleared from circulating blood  
             
Infection of erythrocytes with Plasmodium falciparum has been shown to trigger 
eryptosis, at least in part due to activation of host cell channels via oxidation of the cell 
membrane. Accelerated death of infected erythrocytes has been suggested to delay the 
development of parasitemia and protect against a severe course of the disease. Erythrocyte 
death could be triggered by induction of eryptosis. Triggers of eryptosis include 
hemolysin, PGE2, platelet activating factor, heavy metals like mercury, iron deficiency, L-
NAME, Pb(NO3)2 or chlorpromazine. The present studies has been performed to explore 
whether the addition of L-NAME or Pb(NO3)2 or chlorpromazine to the drinking water 
may modify the course of malaria and survival of  Plasmodium berghei -infected mice and 
also to explore whether iron deficiency influences the course of malaria.  
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 As a result, iron deficiency increased the phosphatidylserine exposure in P.  
falciparum infected human erythrocytes, an effect significantly more marked in iron 
deficiency erythrocytes than compared to control erythrocytes. Moreover, iron deficiency 
impairs in vitro intraerythrocytic growth and infection of erythrocytes. In mice, iron deficient 
erythrocytes are more rapidly cleared from circulating blood, an effect increased by 
infection with P. berghei. Parasitemia in P. berghei infected mice was significantly 
decreased (from 54% to 33% of circulating erythrocytes, 20 days after infection) and 
mouse survival significantly enhanced (from 0% to 20%, 30 days after infection) in iron 
deficient mice.  
  
 L-NAME (≥10 µM) increased phosphatidylserine exposure of P. falciparum 
infected human erythrocytes, an effect significantly more marked than in noninfected 
human erythrocytes. In parallel, parasitemia in P. berghei infected mice was significantly 
decreased (from 50% to 18% of circulating erythrocytes 20 days after infection) by 
addition of L-NAME (1mg/ml) to the drinking water. According to CFSE labelling,         
L-NAME treated infected erythrocytes disappeared more rapidly from circulating blood 
than nontreated erythrocytes  
            
 Pb(NO3)2 (≥10 µM) increased phosphatidylserine exposure of P. falciparum 
infected erythrocytes, an effect significantly more marked than in noninfected cells. We 
further show that Pb(NO3)2 treated erythrocytes are more rapidly cleared from circulating 
blood than nontreated erythrocytes. Parasitemia in P. berghei infected mice was 
significantly decreased (from 50% to 18% of circulating erythrocytes 20 days after 
infection) and mouse survival significantly enhanced (from 0% to 38% 30 days after 
infection) by addition of 100 µM Pb(NO3)2 (20 ppm) to the drinking water. The treatment 
did not significantly decrease erythrocyte number and hematocrit in noninfected mice and 
in infected animals mainly triggered the disappearance of P. berghei harbouring 
erythrocytes.  
  
 Chlorpromazine (≥10 µM) during in vitro infection of human erythrocytes increased 
phosphatidylserine exposure and decreased forward scatter. Chlorpromazine did not 
significantly alter intraerythrocytic DNA/RNA amplification but significantly (≥5 µM) 
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decreased in vitro parasitemia. Erythrocytes from chlorpromazine treated mice were more 
rapidly cleared from circulating blood than nontreated erythrocytes. Parasitemia in P. 
berghei infected mice was significantly decreased (from 50% to 28% of circulating 
erythrocytes 22 days after infection) and mouse survival significantly enhanced (from 0% 
to 80% 30 days after infection) upon addition of  1mM chlorpromazine to the drinking 
water from the first day of infection. 
  
 In conclusion, iron deficiency, L-NAME, Pb(NO3)2 or chlorpromazine enhances the 
susceptibility of eythrocytes to eryptosis. As a result, erythrocytes undergo accelerated 
eryptosis following infection with Plasmodium. The accelerated eryptosis precedes the full 
intraerythrocytic maturation of the pathogen and thus blunts the increase of parasitemia. The 
observations support the view that accelerated suicidal death of infected erythrocytes is a host 
mechanism to counteract infection with the intracellular pathogen. The observations may not 
only serve to understand the mechanisms of host defence against the malaria pathogen but 
open new perspectives for pharmacological treatment of this devastating disease.  
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ZUSAMMENFASSUNG 
 
Malaria ist eine verheerende tödliche Krankheit, die jährlich über eine Million 
Menschen das Leben kostet. Der Verlauf dieser Krankheit ist nicht nur vom Erreger 
abhängig, sondern wird auch von bestimmten Merkmalen des Erkrankten stark beeinflusst. 
Möglicherweise verleihen gewisse Mechanismen Schutz vor einem schweren Verlauf der 
Malaria und der Selbstzerstörung der infizierten Zelle. Eine bestimmte Form des 
Erythrozytenselbstmordes ist die so genannte Eryptose, welche durch einen Ca2+-Einstrom 
mit anschließender Aktivierung eines Ca2+-sensitiven K+-Kanals, KCL-Ausstrom und 
Zellschrumpfung und Ca2+-abhängige Aktivierung von Phospholipiden, charakterisiert ist. 
Die Aktivierung von Phospholipiden hat zur Folge, dass die Anordnung der 
Membranphospholipide zusammenbricht und Phosphatidylserine auf der 
Membranaußenseite präsentiert werden. Zusätzlich kommt es zu einer Ca2+-abhängigen 
Aktivierung von Calpain, zum proteolytischem Abbau von Cytoskelettproteinen und zur 
Membranauflösung. Eryptose wird ausgelöst von verschiedenen wohlbekannten 
apoptotischen Stimuli, zu denen der hyperosmotische Schock, oxidativer Stress und 
Energiemangel gehören. Diese aktivieren jeweils einen unselektiven Ca2+-permeablen 
Kationen-Kanal durch den Ca2+ in die Zelle einströmen kann. Eryptose ist beispielsweise 
verstärkt nachzuweisen bei verschiedenen angeborenen Erythrozytendefekten, 
Phosphatmangel, HUS (hämolytisch urämisches Syndrom), Sepsis und Morbus Wilson. 
Da Makrophagen mit speziellen Phosphatidylrezeptoren ausgestattet sind, können sie 
Zellen, welche Phosphatidylserin auf ihrer Oberfläche präsentieren, erkennen, aufnehmen, 
abbauen und auf diese Weise aus dem zirkulierenden Blut entfernen. 
 
Es konnte gezeigt werden, dass eine Infektion mit Plasmodium falciparum 
Eryptose auslösen kann. Teilweise erfolgt dies durch die Aktivierung von Kanälen der 
infizierten Zelle durch Oxidation der Zellmembran. Beschleunigter Zelltod infizierter 
Erythrozyten geht einher mit einer Verzögerung der Entwicklung einer Parasitämie und 
schützt vor einem schweren Verlauf der Krankheit. Erythrozytenzelltod könnte durch die 
Induktion der Eryptose ausgelöst werden. Faktoren, die Eryptose verursachen, sind 
Hämolysin, PGE2, PAF (Plättchen aktivierender Faktor), Schwermetalle wie Quecksilber 
und Blei (Pb(NO3)2),  Eisenmangel,   L-NAME oder Chlorpromazine. Die vorliegende 
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Studie wurde durchgeführt um erklären zu können, ob die Zugabe von L-NAME, 
Pb(NO3)2 oder Chlorpromazine zum Trinkwasser den Verlauf der Malaria und das 
Überleben von mit Plasmodien berghei-infizierten Mäusen beeinflusst und ob 
Eisenmangel die Schwere des Verlaufs der Krankheit beeinflussen kann.  
Eisenmangel erhöhte tatsächlich die Phosphatidylserinexposition  bei mit P. falciparum 
infizierte Erythrozyten. Der Effekt, der bei Eisenmangelerythrozyten gemessen werden 
konnte, war signifikant erhöht im Vergleich zu den Kontrollzellen. Darüber hinaus 
beeinträchtigt Eisenmangel in vitro intraerythrozytäres Wachstum und Infektion der 
Erythrozyten. In Mäusen werden Eisenmangelerythrozyten schneller aus dem 
zirkulierenden Blut entfernt, ein Effekt, der durch eine Infektion mit P. berghei noch 
verstärkt wird. Die Parasitämie bei mit P. berghei infizierten Mäusen nahm signifikant ab 
(von 54% auf 33% der zirkulierenden Erythrozyten, 20 Tage nach Infektion) und die 
Überlebenszeit der Eisenmangel-Mäuse war im Vergleich zur Kontrollgruppe signifikant 
verlängert (von 0% auf 20%, 30 Tage nach Infektion). 
 
L-NAME (≥ 10µM) erhöhte die Phosphatidylserinexposition von P. falciparum 
infizierter menschlicher Erythrozyten signifikant im Vergleich zu  nichtinfizierten. 
Gleichzeitig war die Parasitämie in P. berghei infizierten Mäusen durch Zugabe von L-
NAME (1mg/ml) zum Trinkwasser signifikant vermindert (von 50% auf 18% der 
zirkulierenden Erythrozyten 20 Tage nach Infektion). Dazu übereinstimmend zeigten 
Versuche mit CFSE-Markierung, dass L-NAME behandelte infizierte Erythrozyten 
schneller aus dem zirkulierenden Blut beseitigt werden als unbehandelte Erythrozyten. 
 
Pb(NO3)2  (≥ 10 µM) erhöhte im Vergleich zu nichtinfizierten Zellen die 
Phosphatidylserinexposition P. falciparum infizierter Erythrozyten signifikant. Des 
Weiteren konnten wir zeigen, dass mit Pb(NO3)2  behandelte Erythrozyten schneller aus 
dem peripheren Blut beseitigt werden als unbehandelte. Die Parasitämie bei P. berghei 
infizierten Mäusen wurde (von 50% auf 18% der zirkulierenden Erythrozyten, 20 Tage 
nach Infektion) durch den Zusatz von 100µM Pb(NO3)2 (20ppm) im Trinkwasser 
signifikant vermindert, ebenso verlängerte sich die Überlebenszeit der Mäuse (von 0% auf 
38% 30 Tage nach Infektion) signifikant. Durch die Behandlung verringerten sich 
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Hämatokrit und Erythrozytenzahl in beiden Gruppen nicht signifikant, sie führte 
hauptsächlich zur Beseitigung der P. berghei-haltigen Erythrozyten.  
 
Chlorpromazine (≥10 µM) erhöhte die Phosphatidylexposition während der in vitro 
Infektion menschlicher Erythrozyten und senkte den Forward Scatter. Chlorpromazine 
hatte keinen signifikanten Einfluss auf die intraerythrozytäre DNS/RNS-Vervielfältigung, 
erniedrigte jedoch die in vitro gemessene Parasitämie signifikant (≥5 µM). Die roten 
Blutkörperchen Chlorpromazine behandelter Mäuse wurden schneller aus dem 
zirkulierenden Blut beseitigt als die von unbehandelten. Die Parasitämie P. berghei 
infizierter Mäuse nahm signifikant ab (von 50% auf 28% der zirkulierenden Zellen 22 
Tage nach Infektion) nach Zugabe von 1mM Chlorpromazine zum Trinkwasser vom ersten 
Tag an der Infektion. 
 
Zusammengefasst erhöhen Eisenmangel, L-NAME, Pb(NO3)2  oder 
Chlorpromazine die Empfindlichkeit der Erythrozyten gegenüber der Eryptose. Wir kamen 
zu dem Ergebnis, dass Erythrozyten nach Infektion mit Plasmodien beschleunigt 
eryptotisch werden. Die forcierte Eryptose erschwert die komplette intraerythrozytäre 
Reifung des Erregers und verhindert so ein Ansteigen der Parasitämie. Die Beobachtungen 
unterstützen die Ansicht, beschleunigter selbstinduzierter Zelltod infizierter Erythrozyten 
könnte ein Mechanismus des Wirts sein, der Infektion mit dem intrazellulären Erreger 
entgegenzuwirken. Sie könnten nicht nur dazu dienen, die Abwehrmechanismen des Wirts 
gegen den Malariaerreger zu verstehen, sondern auch neue Perspektiven für die 
pharmakologische Behandlung dieser verheerenden Krankheit bieten. 
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I. INTRODUCTION 
 
I. Malaria 
Malaria is one of the most important diseases of the developing world. It claims 
more than one million deaths per year. The term malaria (from the Italian mala “bad” and 
aria “air”) was used by the Italians to describe the cause of intermittent fevers associated 
with exposure to marsh air or miasma. About 40% of the world’s population is at risk of 
malaria. It continues to be a huge social, economical and health problem, particularly in 
the tropical countries [Sachs and Malaney 2002]. The prevalence of malaria has caused 
global concern and eradication of malaria has become a tough challenge for the scientist’s 
world wide. Malaria was wide spread over many regions of the world. The figure 1 shows 
the world wide distribution of malaria. 
 
 
 
 
Fig. 1: World wide distribution of malaria 2005 (www.who.int) 
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I. 1. History, transmission and life cycle of the malaria parasite  
I. 1. 1. History 
Mentions of malaria can be found in the ancient Roman, Chinese, Indian and 
Egyptian manuscripts. Hippocrates was probably the first malariologist. By 400 B.C. he 
described the various malaria fevers of man [Grmek 1988]. In 1696, Morton presented the 
first detailed description of the clinical picture of malaria and its treatment with cinchona. 
Charles Louis Alphonse Laveran, a French physician identified the malaria parasite 
[Sherman 2005] and it was Sir Ronald Ross who showed that malaria is transmitted by 
mosquitoes and described the life cycle of malaria [Ross 1897 a,b]. 
 
I. 1. 2. Transmission of malaria 
Malaria is caused by intracellular parasites of the genus Plasmodium that are spread 
from person to person through the bites of infected female Anopheles mosquito which is 
the vector for human malaria. Nearly 60 species of this mosquito have been identified as 
vectors for malaria, and their distribution varies depending upon the geographic regions. 
There are four identified species of the Plasmodium parasite causing human malaria 
namely, Plasmodium vivax, P. falciparum, P. ovale and P. malariae. P. falciparum is wide 
spread in Africa and is the most dangerous causing fatal cerebral malaria and resulting in 
high mortality. When a mosquito bites an infected individual, it aspirates the gametocytes, 
the sexual forms of the parasite, along with blood. These gametocytes continue the sexual 
phase of the cycle and develop into sporozoites that migrate through the salivary glands of 
the infested mosquito. When the female mosquito bites the man for a blood meal, it 
inoculates the sporozoites into human blood stream, thus spreading the infection. 
 
I. 1. 3. Life cycle of Plasmodium 
 
I. 1. 3. 1. Asexual Phase in Human host  
Sporozoites are injected by the mosquito into the subcutaneous tissue and travel to 
the liver either directly or through lymphatic channels. They reach the liver in 30-40 
minutes by brisk motility conferred by circum sporozoite protein (CSP). Approximately 8-
15 sporozoites are injected and hence only a few hepatocytes are infected, therefore this 
stage of the infection causes no symptoms (rarely however, a prodromal illness 
characterised by vague aches and pains, headache, nausea etc. may be present). Recent 
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evidence indicates that sporozoites pass through several hepatocytes before invasion 
[Fujioka and Aikawa 2002]. The co-receptor on sporozoites for invasion involves, in part, 
the thrombospondin domains on the circum sporozoite protein and on thrombospondin-
related adhesive protein (TRAP) [Robson et al., 1998]. These domains bind specifically to 
heparin sulfate proteoglycans on hepatocytes in the region in apposition to sinusoidal 
endothelium and kuppfer cells. Within the hepatocyte, each sporozoite divides into 10000-
30000 merozoites. This stage is called exo-erythrocytic or pre-erythrocytic schizogony.  At 
the completion of this phase, thousands of extra erythrocytic merozoites are released from 
each liver cell [Sherman 1998]. The time taken for the completion of the tissue phase is 
variable, depending on the infecting species (8 - 25 days for P. falciparum, 8 - 27 days for 
P. vivax, 9 - 17 days for P. ovale, and 15 - 30 days for P. malariae) and this interval is 
called as the pre-patent period. In case of P. vivax and P. ovale, some sporozoites may go 
into hibernation - the cryptobiotic phase in which they are called as hypnozoites. They can 
lie dormant for months or years and on reactivation they cause clinical relapse. At the 
completion of the pre-erythrocytic schizogony, the mature schizonts rupture the liver cells 
and escape into the blood, wherein they infect red blood cells. These infective forms are 
called merozoites and they continue their growth and multiplication within the red blood 
cells. 
 
I. 1. 3. 2. The asexual phase in the mosquito  
The merozoites released from the liver cells attach onto the red blood cell 
membrane and by a process of invagination, enter the red cell. Within the red blood cell, 
the asexual division starts and the parasites develop through the stages of rings, 
trophozoites, early schizonts and mature schizonts, each schizont develops into 8-32 new 
merozoites. These merozoites are released by the lysis of the red blood cell and 
immediately invade uninfected red cells. This repetitive cycle of invasion - multiplication - 
release - invasion continues.  The growth and multiplication cycle within the RBCs 
(erythrocytic schizogony) takes about 48 hours for one cycle (72 hours in case of P. 
malariae). A small proportion of the merozoites in the red blood cells undergo 
transformation into male and female gametocytes. Mature gametocytes appear in the 
peripheral blood after a variable period and enter the mosquito when it bites an infected 
individual [Sinden and Smalley 1979].  
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Fig. 2: Life cycle of Plasmodium 
 
I. 1. 3. 3. The sexual phase in the mosquito: Sporogony 
The gametocytes continue their development in the mosquito. The male and female 
gametes fuse and form a zygote. This transforms into an ookinete which penetrates the gut 
wall and becomes an oocyst. The oocyst divides asexually into numerous sporozoites 
which reach the salivary gland of the mosquito. On biting a man, these sporozoites are 
inoculated into human blood stream. The sporogony in the mosquito takes about 10 - 20 
days depending on the species and thereafter the mosquito remains infective for 1 - 2 
months. A diagrammatic representation of the life cycle of Plasmodium is shown in Fig. 2.   
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I. 2.  Invasion into the erythrocyte 
The sequence of invasion is probably similar for all Plasmodium spp. The 
merozoite first attaches to red blood cells. After the attachment to the red cell, the 
merozoite reorients itself so that apposition of apical end occurs. This is followed by 
localized invagination and interiorization of the merozoite. The entire process of invasion 
is completed in 30 seconds. In P. falciparum, erythrocyte binding antigen 175 and 
merozoite surface protein 1, 2 with sialoglycoproteins have been identified as the ligands 
[Soldati et al., 2004] and in P. vivax, duffy antigen on RBC is the site of binding.  
After invasion into RBC the parasite depends on the host cell for its nutrition. The 
parasite has complex metabolic processes. It utilizes amino acids from hemoglobin and 
detoxifies heme. The toxic heme is in turn detoxified by heme polymerase and 
sequestrated as hemozoin (malaria pigment) [Egan et al., 2002].  It has been found that the 
parasites increase the permeability of RBC to get nutrients, yet maintain the RBC structure 
for 48 hours, allowing the immature parasite to survive. At the end, RBC ruptures and each 
schizont releases 6-36 merozoites 
I. 3. Clinical manifestation and treatment of malaria 
Malaria is a febrile illness characterised by fever and related symptoms. All the 
clinical features of malaria are caused by the erythrocytic schizogony in the blood. The 
growing parasite progressively consumes and degrades intracellular proteins, principally 
hemoglobin, resulting in formation of the 'malarial pigment' and hemolysis of the infected 
red cell. This also alters the transport properties of the red cell membrane, and the red cell 
becomes more spherical and less deformable. The rupture of red blood cells by merozoites 
releases certain factors and toxins (such as red cell membrane lipid, glycosyl phosphatidyl 
inositol anchor of a parasite membrane protein), which could directly induce the release of 
cytokines such as TNF and interleukin-1 from macrophages, resulting in chills and high 
grade fever [Sherman 1998]. This occurs corresponding to the erythrocytic cycle. Typical 
features include three stages viz. cold stage, hot stage and sweating stage. The febrile 
episode starts with shaking chills, that lasts from 15 minutes to 1 hour (the cold stage), 
followed by high grade fever, even reaching above 1060 F, which lasts 2 to 6 hours (the hot 
stage). This is followed by profuse sweating and the fever gradually subsides over 2-4 
hours. These typical features are seen after the infection gets established for about a week. 
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The febrile paroxysms are usually accompanied by head aches, vomiting, delirium, anxiety 
and restlessness. As the disease gets established, the patient starts getting relapse of 
symptoms at regular intervals of 48-72 hours. In P. vivax malaria, the young red blood 
cells are predominantly infected, while in P. falciparum malaria, red blood cells of all ages 
are affected. Thus the infective load and severity of infection are more in case of              
P. falciparum malaria.   
 
I. 4. Erythrocyte cell death  
 
I. 4. 1. Apoptosis of nucleated cells 
Abundant, defective or potentially harmful nucleated cells are disposed by 
apoptosis or programmed cell death (PCD) [Bergamo et al., 2004; Brand et al., 2003; 
Green and Reed 1998; Long et al., 2003; Sturm et al., 2004; Wenzel and Daniel 2004] 
which is a biologically regulated process of self-destruction. Apoptotic cell death is 
distinguished from necrotic cell death in the morphological terms described below. 
Additionally, necrotic cell death is a passive process due to an acute cellular injury, where 
as apoptotic cell death is an active process that requires participation of the dying cell and 
changes in cellular biochemistry. Apoptosis allows the elimination of the cells without the 
release of intracellular materials into the extra cellular space and hence it usually does not 
cause inflammation [Gulbins et al., 2000] whereas necrosis leads to cell disintegration and 
the induction of unspecific and/or specific immune response. Apoptosis can be 
characterized by a series of stereotyped changes affecting the nucleus, cytoplasm and 
plasma membrane. It leads to the dismantling of the dying cell and to its rapid ingestion by 
macrophages or other neighbouring cells [Bratosin et al., 2001]. Hallmarks of apoptosis 
include nuclear condensation, DNA fragmentation, mitochondrial depolarization, cell 
shrinkage and breakdown of phosphatidylserine asymmetry of the plasma membrane 
[Green and Reed 1998, Gulbins et al., 2000]. In mammalian cells, there are two major 
apoptotic pathways that usually operate together and amplify each other. One involves the 
proteolytic activation of a family of aspartate-directed cysteine proteinases, the effector 
caspases. Another pathway involves mitochondrial outer membrane permeabilization. This 
permeabilization leads to the release of mitochondrial pro-apoptotic proteins into the 
cytosol. These proteins might either induce caspase activation, such as cytochrome c and 
Smac/Diablo, or might trigger caspase-independent effector pathways such as apoptosis-
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inducing factor (AIF) [Bratosin et al., 2001]. Most, if not all, pro-apoptotic stimuli appear 
to require a mitochondrion-dependent step. Therefore, mitochondria have been proposed to 
play a central role in PCD [Bratosin et al., 2001, Green and Reed 1998].  
 
I. 4. 2. Apoptosis of erythrocytes (Eryptosis) 
Erythrocytes are devoid of nuclei and mitochondria and thus lack crucial elements 
in the machinery of apoptosis. However, similar to other cell types, erythrocytes have to be 
eliminated when they are defective or after their physiological life span of 120 days 
[Bratosin et al., 2001] in case of human beings. Due to the lack of key organelles involved 
in the process of apoptosis it was considered that erythrocytes are unable to undergo 
apoptosis and hence have to be eliminated by mechanisms other than apoptosis. It has been 
observed that erythrocyte senescence is associated with cell shrinkage, plasma membrane 
microvesiculation, a progressive shape change from a discocyte to a spherocyte, 
cytoskeleton alterations associated with protein (spectrin) degradation, and loss of plasma 
membrane phospholipid asymmetry leading to the externalization of phosphatidylserine in 
the erythrocyte membrane [Bratosin et al., 2001; Lang et al., 2005c]. The exposure of 
phosphatidylserine and further eat-me-signals at the cell surface triggers, and the decrease 
of cell volume facilitates, the engulfment of the dying cells by phagocytes [Boas et al., 
1998; Eda and Sherman 2002]. In vitro storage of erythrocytes leads to the gradual 
accumulation of these modifications, and ex vivo, a very small subpopulation of human 
erythrocytes with a senescent phenotype can be isolated from the peripheral blood [Boas et 
al., 1998]. These modifications associated with erythrocyte senescence share striking 
similarities with some cytoplasmic features of apoptosis in nucleated cells.  Recent 
observations have shown that PCD is not limited to nucleated cells but could similarly 
affect erythrocytes [Barvitenko et al., 2005; Bosman and Willekens 2005; Rice and Alfrey 
2005]. Human erythrocytes activate non-selective cation (NSC) channels upon various 
stimuli which induce apoptosis-like death of mature erythrocytes. Hence, the term 
“eryptosis” was coined recently (Lang et al., 2005c) to describe erythrocyte cell death 
characterised by cell shrinkage and breakdown of phospatidyl symmetry, both typical 
features of apoptosis in nucleated cells [Lang et al., 2003 a,b,c,d]. 
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I. 4. 3. Mechanisms of erythrocyte cell death or eryptosis 
There are two major mechanisms of erpytosis that have been illustrated so far. 
There are calcium and lipid (ceramide)-mediated mechanisms. The role of cation channels 
have been identified in eryptosis. Usually erythrocyte cell membranes are tight and show 
little channel activity. Moreover, the erythrocytes are predominantly permeable to Cl- 
[Bernhardt and Ellory 2003]. Osmotic cell shrinkage, however, activates non-selective 
cation channels in the erythrocyte cell membrane [Huber et al., 2001]. The same channels 
are activated by oxidative stress [Duranton et al., 2002]. Energy depletion impairs the 
replenishment of GSH and thus weakens the antioxidative defense of the erythrocytes 
[Bilmen et al., 2001; Mavelli et al 1984]. Accordingly, energy depletion similarly activates 
the cation channels [Lang et al 2002b]. The channels are not only permeable to 
monovalent cations but as well to Ca2+ [Duranton et al., 2002; Kaestner et al., 2000; Lang 
et al., 2003a]. Accordingly, exposure to osmotic shock or oxidative stress triggers 
erythrocyte Ca2+ uptake [Lang et al., 2003c]. Erythrocyte “apoptosis” can be induced by 
increase of intracellular [Ca2+], e.g. by exposition of erythrocytes to the ionophore 
ionomycin. This fact suggests that the cation channel play an important role in erythrocyte 
“apoptosis”  [Lang  et al.,2003a]. 
The influx of intracellular Ca2+ stimulates the erythrocyte scramblase [Zhou et al., 
2002], thus leading to the breakdown of phosphatidylserine asymmetry [Lang et al., 
2003a]. The phosphatidylserine exposure following osmotic shock is blunted by amiloride 
[Lang et al., 2003d] and ethylisopropylamiloride (EIPA) [Lang et al., 2003d], inhibitors of 
the cation channel [Huber et al., 2001, Lang et al., 2003d]. Thus, it appears that activation 
of the cell volume and oxidant sensitive cation channel and subsequent Ca2+ entry 
contribute to the stimulation of erythrocyte scramblase following osmotic shock or 
oxidative stress. Intriguing evidence points to the role of prostaglandins in the regulation 
of eryptosis. Hyperosmotic shock and Cl- removal trigger the release of prostaglandin E2 
(PGE2) [Lang et al., 2005d]. PGE2 in turn activates the cation channels [Lang et al., 
2005d], increases the cytosolic Ca2+ concentration [Lang et al., 2005d] and stimulates 
phosphatidylserine exposure at the erythrocyte surface [Lang et al., 2005b]. The activation 
of the cation channels by Cl- removal is abolished by the cyclooxygenase inhibitor 
diclophenac [Lang et al., 2005d]. Moreover, phospholipase-A2 inhibitors quinacrine and 
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palmitoyl trifluoromethyl ketone and cyclooxygenase inhibitors acetylsalicylic acid and 
diclophenac blunt the increase of phosphatidylserine exposure following Cl- removal 
[Lang et al., 2005d]. PGE2 further activates the Ca2+ dependent cysteine endopeptidase 
calpain, an effect, however, apparently not required for stimulation of phosphatidylserine 
exposure [Lang et al., 2005d]. Ca2+ entering erythrocyte does not only activate the 
scramblase but in addition stimulates the Ca2+ sensitive “Gardos” K+ channels in 
erythrocytes [Bookchin et al., 1987; Franco et al., 1996]. The activation of the channels 
leads to hyperpolarization of the cell membrane driving Cl- in parallel to K+ out of the cell. 
The cellular loss of KCl and osmotically obliged water results in cell shrinkage. Moreover, 
the cellular loss of K+ presumably participates in the triggering of “eryptosis” [Lang et al., 
2003b]. Increase of extra cellular K+ or pharmacological inhibition of the Gardos channels 
by clotrimazole or charybdotoxin do not only blunt the cell shrinkage but also decrease the 
phosphatidylserine exposure following exposure to ionomycin [Lang et al., 2003b,c]. 
Presumably, cellular loss of K+ somehow stimulates eryptosis as has been shown for 
apoptosis of nucleated cells [Bortner et al., 1997; Bortner et al., 1999]. As PGE2 increases 
cytosolic Ca2+ activity [Lang et al., 2005d], it similarly activates the Ca2+ sensitive 
“Gardos” K+ channels with subsequent cell shrinkage [Allen and Rasmussen 1971; Li et 
al., 1996]. The effect of osmotic shock on phosphatidylserine exposure is not fully blocked 
in the absence of calcium [Lang et al., 2003d],  pointing to the participation of a 
mechanism other than nonselective cation and Ca2+ sensitive K+ channels.  
Further experiments revealed that C6-ceramide as well as treatment with bacterial 
sphingomyelinase triggers eryptosis [Lang et al., 2003d]. Osmotic shock leads to the 
appearance of ceramide at the erythrocyte surface [Lang et al., 2004b]. Moreover, 
eryptosis induced by osmotic shock can be inhibited by the sphingomyelinase inhibitor 
3,4-dichloroisocoumarin. Ceramides have been reported to form large channels in the outer 
mitochondrial membrane allowing the release of inter membrane space proteins with a 
molecular weight cut-off of about 60,000 [Siskind et al., 2002]. However, it was shown 
here that C6-ceramide does not enhance Ca2+ uptake of erythrocytes. A simple channel-
based mechanism of the ceramide effect is therefore rather unlikely. Moreover, the 
ceramide induced eryptosis is blunted but not abolished in the nominal absence of Ca2+. 
Thus, C6-ceramide induced cell death is probably not secondary to increase of cytosolic 
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Ca2+ activity. Instead, the effect of C6-ceramide adds to or even potentiates the effects of 
Ca2+ entry on phosphatidylserine exposure. This novel activity of ceramide may be due to 
ceramide-mediated induction of trans bilayer lipid movement as previously demonstrated 
in large unilamellar vesicles and in erythrocyte ghost membranes [Contreras et al., 2003]. 
Accordingly, in the presence of C6-ceramide eryptosis following osmotic shock is 
accelerated. 
Cell shrinkage leads to release of platelet activating factor (PAF), a phospholipid 
mediator involved in the regulation of inflammation, thrombosis, atherogenesis and 
cardiovascular function [Goggel et al., 2004; Haynes and Obiako 2002; Montrucchio et al., 
1993; Subbanagounder et al., 2002; Zimmerman et al., 2002]. PAF in turn stimulates the 
breakdown of sphingomyelin and release of ceramide from erythrocytes [Lang et al., 
2005b]. PAF further triggers cell shrinkage (decrease of forward scatter) and 
phosphatidylserine exposure (annexin binding) of erythrocytes. The stimulation of 
phosphatidylserine exposure is blunted by genetic knockout of PAF receptors (PAF 
receptor knockout mice), and by the PAF receptor antagonist ABT491 [Lang et al., 
2005b]. Thus, PAF participates in the stimulation of sphingomyelinase activation and 
“eryptosis”. PAF further activates Ca2+ sensitive K+ channels (Gardos channels) in the 
erythrocyte cell membrane [Garay and Braquet 1986] by sensitizing them for the 
stimulating effects of cytosolic Ca2+ [Rivera et al., 2002]. Interestingly, PAF is released 
from erythrocyte progenitor cells upon increase of cytosolic Ca2+ activity [Dupuis et al., 
1997].  
As summarized in Fig. 3, cellular stress, e.g. osmotic shock, oxidative stress or 
energy depletion, activate a Ca2+ permeable cation channel in the erythrocyte cell 
membrane presumably via generation of PGE2. The subsequent entry of Ca2+ leads to 
activation of a Ca2+ sensitive scramblase which exposes phosphatidylserine at the surface 
of the erythrocyte cell membrane.  Moreover, activation of the Ca2+ sensitive Gardos K+ 
channels counteracts cell swelling and prevents hemolysis. Eryptosis is further stimulated 
by ceramide which is formed in shrunken erythrocytes by PAF-mediated activation of 
sphingomyelinase. Those mechanisms serve to safely eliminate defective, leaky 
erythrocytes before they rupture and thus release cytosolic components including 
hemoglobin. Similar mechanisms may be operative in nucleated cells where they may be 
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hidden by the more complex apoptotic machinery. Thus, eryptosis may prove to be a 
valuable model system to analyze mechanisms which are similarly important for the 
apoptosis of nucleated cells.  
 
 
Fig. 3: Mechanisms involved in eryptosis. Note that there are Ca2+- and lipid- (ceramide)-
mediated mechanisms. AA: arachidonic acid; COX: cyclooxygenase; NSC: nonselective 
cation channel; PAF, platelet activating factor; PGE2: prostaglandin E2; PLA, 
phospholipase A2; S, scramblase; SM, sphingomyelinase. 
 
I. 4. 4. Physiological significance of eryptosis 
The mechanisms described here could well participate in the limitation of 
erythrocyte survival.  Erythrocyte ageing is paralleled by increase of cytosolic Ca2+ 
activity [Kiefer and Snyder 2000, Romero and Romero 1999]. Moreover, oxidative stress 
or defects of antioxidative defense [Damonte et al., 1992] would enhance Ca2+ entry via 
the cation channels and thus accelerate erythrocyte death and clearance from circulating 
blood. During their daily life, erythrocytes are exposed to several stress situations. In 
average they pass once a minute in to the lung where they are exposed to oxidative stress. 
More than once an hour they travel through kidney medulla where they face osmotic 
shock. Erythrocytes have to squeeze through capillaries which are smaller than themselves. 
Thus, the integrity of erythrocytes is constantly challenged. Rupture of erythrocyte cell 
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membranes releases hemoglobin to extracellular fluid which may be filtered at the 
glomerula of the kidney, precipitate in the acid lumen of the tubules, obliterate the tubules 
and thus lead to renal failure. To avoid those complications, erythrocytes, as any other cell, 
require a mechanism allowing them to be disposed without release of intracellular 
components [Lang et al., 2005c]. Several disorders may decrease the life span of mature 
erythrocytes by facilitating erythrocyte “apoptosis”. As a matter of fact, the sensitivity of 
sickle cells and of glucose-6- phosphate dehydrogenase deficient cells to osmotic shock 
and of sickle cells, thalassemic cells and glucose-6- phosphate dehydrogenase deficient 
cells to oxidative stress and to glucose depletion was significantly higher than that of 
control cells [Lang et al., 2002b: Lang et al., 2005c]. This enhanced susceptibility most 
likely contributes to the decrease of erythrocyte life span in those genetic disorders.  
I. 4. 5. Plasmodium infected erythrocytes 
Human erythrocytes maintain cell integrity, stability despite the effect of shear 
forces of blood circulation. This maintenance is achieved through a set of transporters and 
channels which include Band 3 protein, which enhances the blood CO2 – carrying capacity 
and assists in acid base homeostasis [Cabantchick 1999; Gunn et al., 1973; LaCelle and 
Rothsteto 1966], membrane transporters of glucose, nucleoside and purine for fuelling the 
Na/K and Ca pumps via ATP production and of aminoacid and oxidized glutathione 
transport for maintaining the cell redox status [Brugnara 1997]. Before infection, the 
substrate turnover of erythrocytes is low [Kirk 2001]. Since they do not synthesize 
proteins, DNA or membranes, they have no need for amino acids, nucleic acids, lipids or 
vitamins etc. A prerequisite for intracellular survival of pathogens is an adequate supply of 
nutrients and disposal of waste products [Gulbins and Lang 2001]. Additional transport 
systems for nutrient supply and disposal of waste products are needed particularly during 
infection of erythrocytes with the malaria pathogen Plasmodium sp. [Kirk 2001].  The 
replicating Plasmodium, however, has extensive requirements for all the nutrients [Kirk 
2001] and, to fuel the replication process, Plasmodium parasites consume extensive 
amounts of glucose. An infected erythrocyte takes up 40–100 times more glucose than a 
noninfected cell [Kirk 2001] and releases the corresponding amounts of lactic acid [Poole 
and Halestrap 1993].  To gain access to the necessary nutrients and to dispose of waste 
products, Plasmodium permeabilizes host-erythrocytes for a variety of solutes [Ginsburg et 
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al., 1983; Kutner et al., 1982], including organic and inorganic anions [Ginsburg and Kirk 
1998; Kirk et al., 1994; Staines et al., 2001], cations [Kirk and Horner, 1995; Staines et al., 
2001; Duranton et al., 2003], carbohydrates, amino acids, nucleosides [Ginsburg et al., 
1985; Sherman 1979] and small peptides [Ginsburg et al., 1985; El Tahir et al., 2003; Lew 
2004]. A parallel increase of the host erythrocyte membrane permeability and of the 
intraerythrocytic parasite metabolic and biosynthetic activity (from 12-16 h post-invasion 
onwards) has been observed. The in vitro growth of P. falciparum in culture indeed 
requires the presence in the culture medium of a hexose sugar, a purine source [Sherman 
1979; Sherman and Greenan 1984], seven amino acids (cysteine, glutamate, glutamine, 
isoleucine, methionine, proline and tyrosine) [Polet and Conrad 1968] and panthotenate 
[Divo et al., 1985].  
I. 4. 6. Eryptosis in malaria  
Erythrocyte “apoptosis” may be relevant for the intraerythrocytic survival of the 
malaria pathogen Plasmodium. The parasite invades erythrocytes to escape the immune 
system. However, transport across the intact erythrocyte cell membrane is not sufficient to 
meet the excessive demands of the pathogen. Thus, Plasmodium induces novel 
permeability pathways (NPP) allowing the uptake of nutrients and the disposal of waste 
products [Kirk 2001]. Most recent experiments revealed that NPP is made up of 
endogenous host cell channels which are activated by the pathogen through oxidation of 
the cell membrane [Duranton et al., 2003; Huber et al., 2002]. Activation of the cation 
channel is required for the cellular accumulation of Na+ and Ca2+ which are both needed 
by the pathogen. By the same token, however, the activation of the cation channel triggers 
erythrocyte “apoptosis” [Brand et al., 2003]. Presently, it is not entirely clear whether 
phosphatidylserine exposure of infected host cells is favourable for the host or the 
pathogen. In other model systems, host cell apoptosis has proven to be a crucial defence 
mechanism of the host [Grassme et al., 2000]. In any case, erythrocyte “apoptosis” favours 
the recognition of the erythrocytes by macrophages and thus limits the life span of the 
infected cell.  
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I. 5. Rodent malaria parasites as models for human malaria 
A wide range of investigations using rodent parasites have provided knowledge for 
developing and shaping concepts in major areas of research on the human disease. The 
interest of rodent malaria parasites is that they are practical models for the experimental 
study of mammalian malaria. These parasites have proved to be analogous to the malaria 
of man and other primates in most essential aspects of structure, physiology and life cycle 
[Carter and Diggs 1977]. Metabolic pathways are conserved between rodent and human 
malaria parasites. No gross differences in metabolic pathways between mammalian 
malaria parasites have been reported [Homewood and Neame 1980]. The similarity in 
sensitivity of mammalian malaria parasites to anti-malarial drugs and other specific 
inhibitors emphasises the similarities in their metabolic processes. The life cycles and the 
different developmental stages of all rodent and human malaria parasites are highly 
comparable [Aikawa and Seed 1980; Sinden 1978]. Rodent parasites are recognised as 
valuable model parasites for the investigation of the developmental biology of malaria 
parasites, parasite-host interactions, vaccine development and drug testing. The 
Relationship of rodent parasites to other mammalian malaria parasites in brief are: 
• The basic biology of rodent and human parasites is similar. 
• The genome organisation and genetics is conserved between rodent and human 
parasites. [Lin et al., 2004]  
• Housekeeping genes and biochemical processes are conserved between rodent and 
human parasites. 
• Methodologies for genetic modification are available. 
• Rodent hosts with extensively characterised genetic backgrounds and transgenic 
lines are valuable and available tools for immunological studies. 
• The structure and function of vaccine candidate target antigens are conserved 
between rodent and human parasites (for example TRAP and CSP of sporozoites; 
CTRP, P25 and P28 of ookinetes; AMA1 and MSP1 of merozoites; P45/48, P47 
and P230 of gametes). 
• The manipulation of the complete lifecycle of rodent parasites, including mosquito 
infections is simple and safe. 
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• In vitro culture techniques for large-scale production and manipulation of different 
life cycle stages are available. For example, in vitro cultures of liver and mosquito 
stages provide tools to investigate the less accessible parts of the life cycle of the 
human  
• The molecular basis of drug-sensitivity and resistance show similar characteristics 
in rodent and human parasites. 
• Rodent parasites allow in vivo investigations of parasite-host interactions and in 
vivo drug testing. 
P. berghei is one of the many species of malaria parasites that infect mammals other 
than humans. A susceptible mosquito vector for P.berghei, which is widely used in the 
laboratory, is Anopheles stephensi. P. berghei infects laboratory hamsters, rats and mice. 
In our studies we have used P. berghei as our in vivo rodent model of malaria.             
 
I. 6. Pathophysiological and pharmacological modification of eryptosis 
Malaria is one of the most devastating diseases with lethal outcome in more than             
1 million humans per year [Planche and Krishna 2005]. Targeting the pathogen with 
antimalarial drugs has only been partially successful because of the spread of drug-resistant 
parasites and the optimal use of effective drugs has always been a major concern. Hence all 
possibilities to combat this disease must be explored. The course of the disease is not only a 
function of the pathogen but is heavily influenced by properties of the host. Hence, studies 
must be carried out to fight infection by altering host physiology which decimates the 
problem of drug resistance and if successful, these approaches may prove extremely useful, 
particularly in the treatment of resistent pathogens. Targeting at the accelerated clearance of 
the infected host cells is expected to provide protection against malaria. Hence, in vivo 
modulation of eryptosis by therapeutic interventions has to be further elucidated. 
.  
I. 6. 1. Influence of iron deficiency on the course of malaria in P. berghei infected mice 
Iron deficiency is a common disorder leading to the development of anemia in 500 
to 600 million people worldwide [Bothwell 1995; Oppenheimer 2001; Planche and Krishna 
2005]. The lack of iron impedes hemoglobin synthesis and the formation of erythrocytes 
with adequate hemoglobin content. Thus, it is generally accepted that iron deficiency-
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induced anemia results at least in part from reduced erythropoiesis [Lang et al., 2004b; 
Spivak 2002].                
              
Most recent observations disclosed that eryptosis is enhanced by iron deficiency 
[Kempe et al., 2006]. The anemia of iron deficiency is not only the result of reduced 
erythropoiesis [Arndt et al., 2005; Brugnara 2003; Rivera et al., 2005; Thomas and Thomas 
2005] but is at least partially due to decreased life span of iron deficient erythrocytes                    
[Ramachandran and Iyer 1984]. Infection of erythrocytes with P. falciparum has been shown 
to trigger eryptosis [Brand et al., 2003], at least in part due to activation of host cell channels 
via oxidation of the cell membrane [Duranton et al., 2003; Huber et al., 2002; Tanneur et al., 
2006]. Mechanisms explaining the accelerated clearance of iron-deficient erythrocytes are 
poorly understood, and it was hitherto assumed that erythrocytes undergo extravascular 
hemolysis, i.e., necrotic cell death. Compelling evidence indicates that the decreased life 
span of iron deficient erythrocytes is the result of premature eryptosis [Kempe et al., 2006]. 
Thus, we hypothesised that the protection against a severe course of malaria may similarly 
be related to accelerated eryptosis. To test this hypothesis, the course of malaria and 
eryptosis of infected and noninfected erythrocytes were studied in iron deficient and iron 
repleted mice following infection with P. berghei. 
 
I. 6. 2. Impact of NO synthase inhibitior L-NAME on the course of malaria 
 
The pleotropic effects of nitric oxide include the regulation of cell survival or 
apoptosis    [Dimmeler et al., 1997; Dimmeler and Zeiher 1999]. Depending on the source 
or concentration of NO and on the influence of additional regulators NO may stimulate or 
inhibit apoptosis [Boas et al., 1998; Brune 2003; Haendeler et al., 1999; Taylor et al., 
2003]. NO is partially effective through S-nitrosylation of target proteins [Dimmeler et al., 
1997]. Moreover, effects of NO donors on Ca2+-induced phosphatidylserine exposure 
could be mimicked by cGMP, pointing to a role of protein  kinase G [Das et al., 2006; Li  
and Billiar 1999; Nagai-Kusuhara et al., 2007]. Intravascular formation of NO may be 
modified by erythrocytes [Crawford et al., 2006; Dejam et al., 2005; Gladwin et al., 2004; 
Grubina et al., 2007; McMahon et al., 2002; Mehta et al., 2000], which may take up both, 
NO and nitrite (NO2-) [Dejam et al., 2005]. Oxyhemoglobin may react with NO to form 
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nitrate (NO3-), desoxygenized hemoglobin may react with nitrite to form NO [Cosby  et al., 
2003; Dejam et al., 2005; Nagababu et al., 2003; Rice and Alfrey 2005; Yang et al., 1996]. 
 
Most recent experiments confirmed that similar to apoptosis of nucleated cells 
[Dimmeler et al., 1997; Dimmeler et al., 2002; Dimmeler and Zeiher 1999; Gotoh et al., 
2004; Haendeler et al., 1999; Hoffmann et al., 2001a; Kim et al., 2005; Li and Billiar 
1999; Liu and Stamler 1999; Taylor et al., 2003; Traister et al., 2004; Wang et al., 2003], 
erythrocyte cell death is subject to regulation by nitric oxide (NO) [Nicolay et al., 2007]. 
In vitro experiments disclosed that NO is a potent inhibitor of eryptosis [Nicolay et al., 
2007]. In vivo experiments indicated that endogeneous formation of NO is required for 
normal erythrocyte life span [Nicolay et al., 2007].  
 
Accelerated eryptosis may confer some protection against a severe course of malaria 
[Lang et al., 2004c]. Accelerated aging or eryptosis of Plasmodium infected erythrocytes with 
sickle-cell trait, beta-thalassemia-trait, homozygous Hb-C or glucose-6-phosphate 
dehydrogenase (G6PD)-deficiency is followed by premature clearance of infected 
erythrocytes thus blunting the increase of parasitemia [Ayi et al., 2004; Cappadoro et al., 
1998; de Jong et al., 2001; Kean et al., 2002; Kuypers et al., 1998; Lang et al., 2002b].  
             The present study has therefore been performed to explore whether inhibition of 
NO synthase acclerates the clearance of circulating erythrocytes during malaria. L-NAME 
(Nω-Nitro-L-arginine methyl ester hydrochloride) which is a non specific NO synthase 
inhibitor was chosen and the mice treated with L-NAME were infected with the malaria 
pathogen P. berghei to explore whether inhibition of NO synthase would indeed influence 
the course of malaria. 
I. 6. 3. Influence of lead treatment on P. berghei infected mice 
Pb+ ions adhere to erythrocyte cell membranes [Suwalsky et al., 2003], decrease the 
erythrocyte ATP concentration [Baranowska-Bosiacka and Hlynczak 2003; Grabowska 
and Guminska 1996], delay the decline of protoporphyrin concentration in mature 
erythrocytes [Lamola et al., 1975; Piomelli et al., 1975], and decrease 5'-nucleotidase 
activity [Valentine et al., 1976]. Pb+ ions have been demonstrated to directly activate Ca2+-
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sensitive Gardos K+ channels in human erythrocytes [Simons 1985] and similar Ca2+-
sensitive K+ channels in other cell types [Cao and Houamed 1999;  Nishizaki 2003].  
Recent experiments revealed the ability of lead to accelerate eryptosis [Kempe et al., 
2005]. Sequelae of lead intoxication include anemia that may be partially due to a 
shortened life span of circulating erythrocytes [Osterode et al., 1999]. However, this 
premature elimination of circulating erythrocytes remains poorly understood.  
Therefore, the present experiments were performed to explore whether the 
treatment with lead influences Plasmodium infected erythrocytes. Thus, in vitro 
experiments have been performed in human erythrocytes and in vivo experiments in mice 
to explore whether lead favours phosphatidylserine exposure of infected erythrocytes, 
accelerates the clearance of circulating erythocytes and thus influences the course of 
malaria. 
I. 6. 4. Influence of chlorpromazine on the course of malaria 
 Chlorpromazine has been recently shown to trigger eryptosis [Akel et al., 2006], the 
suicidal erythrocyte death characterized by cell shrinkage and by exposure of 
phosphatidylserine at the cell surface [Berg et al., 2001; Brand et al., 2003; Bratosin et al., 
2001; Daugas et al., 2001; Lang et al., 2002a]. As macrophages are equipped with receptors 
specific for phosphatidylserine [Fadok et al., 2000; Henson et al., 2001], erythrocytes 
exposing phosphatidylserine at their surface are rapidly recognized, engulfed and degraded 
[Boas et al., 1998; Yamanaka et al., 2005].  
  
 Side effects of treatment with chlorpromazine include anaemia which could result 
from decreased formation or accelerated clearance of circulating erythrocytes. Accelerated 
eryptosis has been suggested to confer some protection against a severe course of malaria 
[Lang et al., 2004c]. Chlorpromazine has indeed been shown to be effective in the treatment 
of malaria [Basco and Le Bras 1992; Kalkanidis et al., 2004; Loria et al., 1999]. However, it 
is poorly understood whether the acclerated clearance of erythrocytes plays a role in the 
antimalarial effect of chlorpromazine. The acclerated clearance of erythrocytes could well 
contribute to the known anaemia observed in the treatment with this antipsychotic drug. 
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 The present experiments have been performed to explore whether chlorpromazine 
triggers phosphatidylserine exposure of infected erythrocytes causing the acclerated 
clearance thus leading to decreased life span of circulating erythrocytes and thus 
influences the clinical course of malaria.  
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II. AIM OF THE STUDY 
Human erythrocytes are subjected to eryptosis which is an apoptosis-like cell death 
characterised by cell shrinkage and breakdown of phospatidyl symmetry.  Eryptosis with 
subsequent phagocytosis leads to the degradation and elimination of defective cells. 
Eryptosis may as well result in the elimination of intracellular pathogens and may serve as 
host defense mechanism. Accelerated eryptosis of Plasmodium-infected RBCs may lead to 
rapid in vivo clearance of infected erythrocytes and may confer protection against severe 
course of malaria. Hence, our present study was aimed to address the following questions. 
  
1. What is the functional significance of suicidal death of erythrocytes (eryptosis) in 
malaria? 
 
2. Does phosphatidylserine exposure play a significant role in the erythrocyte 
clearance and elimination of infected erythrocytes?  
 
3. Does eryptosis induction by pharmacological interventions effect the in vitro 
amplification and growth of the parasite? 
 
4. Does the iron deficiency, L-Name, lead or chlorpromazine modulate eryptosis of 
infected cells and influence the course of malaria in P. berghei infected mice?  
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III.    METHODS  
 
III. 1. Animals: Animal experiments were performed according to German animal protection 
law and approved by the local authorities. In the study involving iron deficiency, C57BL/6 
mice (female aged 4 months) were fed either on control diet (iron content: 180 mg/kg diet; 
protein content: 17 %; and fat content: 5 %; Altromin C1000, Altromin, Lage, Germany) or 
an iron deficient diet (iron content: < 10 mg/kg diet; otherwise identical to control diet; 
Altromin C1038) for 10 weeks. In all the other studies the mice were fed on control diet 
(1314, Altromin, Heidenau, Germany). The control mice had free access to tap water while 
the treated groups received L-NAME (1 mg/ml) or lead in the form of 100 µM Pb(NO3)2 in 
drinking water from the 10th day of infection. The chlorpromazine treated group received 
chlorpromazine (1mM) in drinking water from the 1st day of infection. 
   
The following methods were used in our study where ever applicable. 
 
III. 2. Preparation of human and mouse erythrocytes: Human erythrocytes were drawn 
from healthy volunteers. They were either used without purification or after separation by 
centrifugation for 25 min; 2000 g over Ficoll (Biochrom KG, Berlin, Germany). 
Experiments with non-purified or Ficoll-separated erythrocytes yielded the same results. 
After washing, the buffy coat and upper 10-20% of the red blood cells were discarded and the 
remaining pellet was used for experiments. The RBCs were then resuspended at 10% 
hematocrit and stored at 4°C until use (2-5 days). Experiments were performed at 37°C in 
Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)/NaOH (pH 7.4), 5 glucose, 1 
CaCl2. For the study involving iron deficiency, erythrocyte concentrates were obtained by 
centrifugation/filtration procedures from the blood of healthy volunteers and patients with 
iron deficiency. Patients and healthy donors gave their informed consent and the study was 
approved by the Ethic Committee of the University of Tübingen (project number: 
184/2003V). Erythrocytes were washed three times in Ringer solution, stored in SAG 
mannitol (Haemonetics, Munich, Germany) at 4°C, and washed twice in Ringer solution 
before use. For incubation, the final hematocrit was adjusted to 0.3 %. Mouse erythrocytes 
were drawn from the animals by retroorbital venopuncture. Experiments on mouse 
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erythrocytes were performed at 37°C in Ringer solution containing 125 mM NaCl, 5 mM 
KCl, 1 mM MgSO4, 32 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 
5 mM Glucose, and 1 mM CaCl2, pH 7.4. 
 
III. 3. In vitro culture of plasmodium falcifarum infected human erythrocytes: For 
infection of human erythrocytes, the human pathogen P. falciparum strain BinH [Binh et 
al., 1997] was grown in vitro [Huber et al., 2002] in human erythrocytes. Cultures were 
mainained continuously by routine passage in fresh and stored human erythrocytes. 
Parasites were cultured as described earlier [Jensen and Trager 1978; Trager and Jensen 
1976] at a hematocrit of 2-5% and a parasitemia of 2-10% in RPMI 1640 medium 
supplemented with 0.5% Albumax II (Gibco, Karlsruhe, Germany), 0.13 µM 
hypoxanthine, 2 mM L-glutamine (Gibco, Karlsruhe, Germany), 25 mM HEPES/NaOH 
pH 7.4 (Sigma-Aldrich, Schnelldorf, Germany), 20 µg/ml gentamycin (Gibco, Karlsruhe, 
Germany) in an atmosphere of 90 % N2, 5 % CO2, 5 % O2. 
The dilution factors (Df) for splitting the infected RBCs suspension in order to maintain 
the   P. falciparum in vitro culture were calculated as follows: 
Df = mP * V(RBC) / dP * dV(RBC) 
Fresh blood was added according to the following formula:  
dV(RBC) – (V(RBC) )/ Df 
mP: measured parasitemia; V(RBC): volume of packed erythrocytes in the culture flask; 
dP:desired parasitemia; dV(RBC): desired volume of packed erythrocytes in the flask. The 
volume of the medium was adjusted according to the degree of parasitemia and the time 
until the next medium change [Schlichtherle et al., 2000]. 
 
III. 4. Freezing and defreezing of parasites: From time to time samples with high, i.e. ≥ 
20 % parasitemia, predominantly containing ring stages were deep frozen in liquid 
nitrogen for stock purposes. The cell pellet obtained after centrifugation (450g / 8 min at 
RT) was mixed with an equal volume of freezing solution, sterile transferred to a 2.0 ml 
cryotube vial and directly deep frozen in liquid nitrogen. For defreezing the parasites four 
cryotubes containing infected RBCs (> 20 % parasitemia) were thawed quickly at 37°C in 
a water bath. The contents were transferred to a 15 ml falcon tube and centrifuged (450g / 
4 min at RT). The supernatant was discarded. A volume of sterile filtered 3.5 % NaCl 
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solution equal to V(RBC) was added at a rate of 1 - 2 drops per second while gently shaking 
the tube. Finally the liquid was mixed with a pipette. After centrifugation at 450g for 4 min 
the supernatant was discarded. The RBC pellet was carefully suspended in original RPMI 
1640 medium (2*V(RBC)). Washing was repeated until the supernatant became clear. The 
remaining cell pellet was resuspended in complete medium and transferred to a culture 
flask. Fresh RBCs were added (amount depending on V(RBC)). The culture flask was filled 
with 90% N2 /5% O2 / 5% CO2. 
 
III. 5. Isoosmotic sorbital synchronization of P.  falciparum infected human      
 erythrocytes: The P. falciparum BinH strain was cultured and synchronized to the ring 
stage by sorbitol treatment as described previously [Binh et al. 1997]. Briefly, the infected 
RBCs (>5% parasitemia) were spinned down at 600×g and resuspended in isosmotic 
sorbitol solution (in mM: 290 sorbitol, 5 glucose, 5 HEPES/NaOH, pH 7.4) for 20 min at 
21°C in continous shaking. Then the cells were washed twice in malaria culture medium 
and subculutred for further experiments. 
 
III. 6. In vitro P.  falciparum growth assay: For the in vitro growth assay, synchronized 
parasitized erythrocytes were aliquoted in 96-well plates (200 μl aliquots,0.5- 1% 
hematocrit, 0.5 –2 % parasitemia) and grown for 48 h in serum-free Albumax II (0.5%)-
supplemented RPMI medium as described earlier [Tanneur et al., 2006]. The erythrocytes 
were grown in the presence or absence of (0.1 µM- 100 µM)      L-NAME or Pb2+ ions or 
chlorpromazine. The parasitemia was assessed at time 0 and after    48 h of culture by flow 
cytometry (FACS Calibur, Becton Dickinson, Heidelberg, Germany). Parasitemia was 
defined by the percentage of erythrocytes stained with the DNA/RNA specific 
fluorescence dye Syto16 (20 nM final concentration, Molecular Probes, Göttingen, 
Germany). Briefly, RBCs were incubated with Syto16, diluted in PBS or annexin binding 
buffer at 37°C. The staining procedure was performed for around 30 – 40 min for infected 
human RBCs. Syto16 green fluorescent nucleic acid stain bound to DNA has a maximum 
excitation/absorption wavelength of 488 nm, which corresponds to the argon line of the 
single-laser of the FACS Calibur used, and a maximum emission wavelength of 518 nm. 
Bound to RNA the absorption maximum is at 494 nm, the emission maximum at 525 nm. 
This green emission is detected in the Fluorescence 1 (FL-1) channel with a detector for an 
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emission wavelength of 530 ± 15nm. FACS analysis proved a more sensitive technique for 
determining parasitemia than either Giemsa or Field´s rapid staining.                                    
 
III. 7. Intraerythrocytic DNA amplification of P. falciparum: To estimate the 
DNA/RNA amplification in a further series of experiments, the culture was ring stage-
synchronized and re-synchronized after 6 h of culture (to narrow the developmental 
parasite stage), aliquoted (200 μl aliquots, 2 % hematocrit and 10 % parasitemia) and 
cultured for further 16 h. The erythrocytes were cultured in the presence or absence of (0.1 
µM- 100 µM) L-NAME or Pb2+ ions or chlorpromazine. Thereafter, the DNA/RNA amount 
of the parasitized erythrocytes was determined by Syto16 fluorescence as a measure of 
intraerythrocytic parasite copies.  
 
III. 8. In vivo proliferation of P.  berghei ANKA: For infection of mice P. berghei 
ANKA-parasitized mouse erythrocytes (1x106) were injected intraperitoneally [Huber et al., 
2004] into sex- and age-matched  mice fed on control diet and with free access to drinking 
water or L-NAME (1 mg/ml) or lead (100µM Pb(NO3)2) containing drinking water from 
the 10th day of infection. In the group involving the treatment with chlorpromazine, mice 
were fed on control diet and had free access to drinking water or chlorpromazine (1mM) 
containing drinking water from 1st day of infection. In the study involving iron deficiency, 
the mice were infected after there were fed on control or iron deficient diet for 10 weeks 
and had free access to drinking water through out the study. Parasitemia was determined 
daily form the 8th day of infection by flow cytometry. The blood samples were stained with 
the DNA/RNA-specific fluorescence dye Syto-16 and the Syto-16 fluorescence was 
analysed with a FACS Calibur cytometer (Becton Dickinson , Heidelberg, Germany) at 
fluorescence channel 1 (FL1 488 nm excitation and 530 nm emission as described above. 
III. 9. Fluorescence staining and flourescence microscopy: The Pb2+ effect on annexin 
binding in erythrocytes was further studied using immunofluorescence as described 
previously [Kempe et al., 2005]. After 24-h exposure (37°C) to Pb2+ (0, 0.3, 1, and 3 µM in 
NaCl-Ringer solution), the erythrocytes were suspended for 20 min in annexin-binding 
buffer containing annexin-V-fluos (1:50 dilution), centrifuged, resuspended in NaCl-
Ringer, and postincubated (37°C) for 10 min in a modified Ringer solution containing (in 
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mM) 145 NaCl, 5 KCl, 5 glucose, 1.6 CaCl2, 0.8 MgCl2, and 5 HEPES-NaOH (pH 7.4) to 
wash the cells and to maintain an isosmotic bath condition (298 mosM). Finally, 10 µl of 
the cell suspension were analyzed under a fluorescence microscope (440/480-nm excitation 
and 535/50-nm emission wavelength, Q505LP beamsplitter, AHF Analysentechnik, 
Tübingen, Germany, combined with a Nikon microscope; Düsseldorf, Germany), and 
digital pictures were taken using a digital imaging system (Visitron Systems, Puchheim, 
Germany) equipped with Metaview software. 
III. 10. Determination of phosphatidylserine exposure: FACS analysis was performed 
as described [Kempe et al., 2006]. Suspensions of non infected erythrocytes were stained 
with annexinV-fluos (Roche, Mannheim, Germany), suspensions of P. falciparum infected 
erythrocytes were stained with annexin V-568 (Roche, Germany) and/or with the DNA 
dye Syto16 (Molecular Probes) to depict phosphatidylserine exposing and infected 
erythrocytes, respectively. For annexin binding, erythrocytes were washed, resuspended in 
annexin-binding buffer (140 mM NaCl, 10 mM HEPES, 5 mM Glucose, 5 mM CaCl2. pH 
7.4), stained with annexin V-568 (dilution 1:50) or annexin V-fluos (dilution 1:100), 
incubated for 20 min at room temperature, and diluted 1:5 with annexin binding buffer. 
Syto16 (final concentration of 20 nM) was either directly added to the diluted erythrocyte 
suspension (or incubated for 30 min at 37°C) or co-incubated in the annexin binding 
buffer. Cells were analyzed by flow cytometry (FACS-Calibur, Becton Dickinson) using 
FL-1 for Syto16 or annexin V-fluos fluorescence intensity and with FL-2 for annexin V-
568 fluorescence intensity. 
 
III. 11. Determination of intracellular Ca2+ influx in the erythrocytes: Intracellular 
Ca2+ measurements were performed as described previously [Andrews et al., 2002]. 
Erythrocytes were loaded with fluo-3 AM (Calbiochem, Bad Soden, Germany) by addition 
of fluo-3 AM stock solution (2 mM diluted in DMSO) to 1 ml of erythrocyte suspension 
(0.16% hematocrit in Ringer solution; 4 µM fluo-3 AM final concentration). The cells were 
incubated at 37°C for 15 min under protection from light. An additional 2-µl aliquot of 
fluo-3 AM was added, and then the mixture was incubated for 25 min. Fluo-3-loaded 
erythrocytes were centrifuged at 1,000 g for 5 min at 22°C and then washed twice with 
Ringer solution containing 0.5% bovine serum albumin (Sigma) and once with Ringer 
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solution and incubated. For flow cytometry, fluo-3-loaded erythrocytes were resuspended 
in 1 ml of Ringer solution (0.16% hematocrit) containing 1 µM Pb(NO3)2 and incubated at 
37°C for 30 min. As a positive control, erythrocytes were stimulated with 1 μM Ca2+ 
ionophore ionomycin (Sigma) for 3 min prior to analysis to increase intracellular Ca2+ 
activity. For negative control, cells were incubated for 30 min at 37°C with vehicle alone. 
Subsequently, Ca2+-dependent fluorescence intensity was measured in fluorescence 
channel FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 
nm.  
 
III. 12. Measurement of the in vivo clearance of fluorescence-labelled erythrocytes: 
Fluorescence-labelled erythrocytes from mice were obtained by staining erythrocytes with 
carboxyfluorescein diacetate, succinimidyl ester (CFSE) from Molecular Probes (Leiden, 
The Netherlands). The labelling solution was prepared by addition of adequate amounts of 
a CFSE stock solution (10 mM in DMSO) to phosphate-buffered saline (PBS) to yield a 
final concentration of 5 µM. Then, the cells were incubated with labelling solution for 30 
min at 37°C. The cells were pelleted at 1000 x g for 5 min, washed and resuspended in 
fresh, prewarmed PBS. The fluorescence-labelled erythrocytes were injected into the tail 
veins of mice [Kempe et al., 2006]. At indicated time points, blood was taken from the 
mice and CFSE-dependent fluorescence intensity of the erythrocytes was measured in the 
fluorescence channel FL-1. The percentage of CFSE-positive erythrocytes was calculated 
in % of the whole population. 
 
III. 13. Measurement of the fluorescence-labelled erythrocytes in the spleens of mice: 
The fluorescence-labelled erythrocytes were injected into the tail veins of mice. After 2 
hours the mice were sacrificed and the spleens were dissected and carefully mashed 
through a net. Finally, CFSE-dependent fluorescence intensity of the erythrocytes in spleen 
suspensions was measured in the fluorescence channel FL-1.  
 
III. 14. Analysis of blood cell numbers : Erythrocyte density, packed cell volume, mean 
erythrocyte volume, white blood cell counts, and hemoglobin content were determined 
using an electronic hematology particle counter (type MDM 905) from Medical 
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Diagnostics Marx (Butzbach, Germany), equipped with a photometric unit for hemoglobin 
determinations. 
 
III. 15. Mouse reticulocyte numbers: For determination of relative reticulocyte numbers, 
5 µl of whole blood were added to 1 ml Retic-COUNT (Thiazole orange) reagent from 
Becton Dickinson. Samples were stained for 30 min at room temperature in the dark. Then, 
FACS analysis of stained samples was performed according to the manufacturer’s 
instructions. Forward scatter (FSC), side scatter (SSC), and thiazole orange-fluorescence 
intensity (in the fluorescence channel FL-1) of the blood cells were measured on a FACS-
Calibur from Becton Dickinson. Finally, the numbers of Retic-COUNT positive 
reticulocytes were determined and relative reticulocyte numbers were expressed as 
percentages of the total, gated erythrocyte populations. Gating of erythrocytes was 
achieved by analysis of FSC vs. SSC dot plots using the CellQuestTM software. 
III. 16. Data analysis and statistics: Data are provided as means ± standard error of mean 
(SEM), n represents the number of independent experiments. Statistical analysis was made 
by paired or unpaired t test or by ANOVA using Dunnett’s or Tukey’s test as post hoc test, 
where appropriate. P ≤ 0.05 was considered statistically significant. 
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IV.   RESULTS 
 
IV. 1. Influence of iron deficiency on the course of malaria in P.  berghei    
           infected mice 
IV. 1. 1. Annexin binding of noninfected and infected erythrocytes from control and 
iron deficient patients: To elucidate whether iron deficiency or infection with                   
P. falciparum modifies the percentage of cells exposing phosphatidylserine at the cell 
surface, we determined annexin binding in FACS analysis. The percentage of annexin-
positive erythrocytes in freshly drawn blood was low in both, patients with iron deficiency 
(0.42 ± 0.02 %, n = 6) and healthy individuals (0.46 ± 0.16 %, n = 8). A 24 hour 
incubation in RPMI 1640 medium increased the percentage of annexin binding cells in 
blood from patients with iron deficiency to values (5.75 ± 0.07 %, n = 12) significantly (p 
≤ 0.05, two-tailed t-test) higher than in blood from healthy individuals (3.94 ± 0.08 %, n = 
12). As illustrated in Fig. 4, 48 h in vitro infection significantly enhanced the percentage of 
annexin binding infected erythrocytes as compared to the co-cultured uninfected 
erythrocytes. The increase was significantly higher in erythrocytes from iron deficient 
patients than in erythrocytes from healthy individuals (Fig. 4B). Thus, iron deficiency 
increases the effect of infection on eryptosis. 
 
 IV. 1. 2. Intra erythrocytic DNA amplification: To test for intraerythrocytic amplification 
infected erythrocytes were ring-stage synchronized and cultured for further 24h. As a 
result, iron deficiency slightly but significantly decreased the DNA/RNA content (Fig.5). 
This points to a delayed intraerythrocytic growth of the parasite in iron-deficient 
erythrocytes as compared to control erythrocytes. 
 
IV. 1. 3. In vitro growth of P. falciparum in erythrocytes of control and iron deficient 
patients: Moreover, the number of infected erythrocytes was markedly decreased 
following 48 h of incubation (Fig. 6). This decrease of parasite growth might be due to 
impaired intraerythrocytic parasite amplification and/or due to an impaired reinvasion. 
Comparison of the Fig. 6 (DNA/RNA content prior to parasite release and re-invasion) and 
Fig. 7 (number of parasitized cells after parasite re-invasion) suggests that in addition to 
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intraerythrocytic parasite amplification the invasion into iron deficient erythrocytes was 
impaired.  
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Fig. 4: Effects of iron deficiency on phosphatidylserine exposure of infected and non 
infected human erythrocytes  
A. Dot blots of annexin binding and Syto16 fluorescence of human erythrocytes from 
healthy individuals (left panels) and iron deficient patients (right panels) prior to (upper 
panels) and 48 hours after (lower panels) infection with P.  falciparum. 
B) 
103 104
102
104
101
103
100
100 101 102 103 104
102
104
101
103
100
100 101 102 103 104
A
nn
ex
in
V
 fl
uo
re
sc
en
ce
[r
el
. u
ni
ts
]
 37 
B. Arithmetic means ± SEM (n = 6) of annexin binding after 48 h incubation of 
noninfected (left bars) and infected (right bars) erythrocytes from healthy individuals 
(open bars) or iron deficient individuals (closed bars).* indicates significant difference (p ≤ 
0.05) to erythrocytes from healthy individuals, # indicates significant difference between 
infected and noninfected erythrocytes. 
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Fig. 5: Effects of iron deficiency on intra erythrocytic DNA amplification of infected 
and noninfected human erythrocytes 
Arithmetic means ± SEM (n = 8) of DNA amplification in erythrocytes from healthy 
individuals (open bars) or iron deficient individuals (closed bars). * indicates significant 
difference (p ≤ 0.05) to erythrocytes from healthy individuals. 
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Fig. 6: Effects of iron deficiency on in vitro growth of P. falcifarum in erythrocytes of 
control and iron deficient patients.  
Arithmetic means ± SEM (n = 8) of parasitemia after in vitro growth of P. falciparum in 
erythrocytes of healthy individuals (open bars) and iron deficient patients (closed bars).     
* indicates significant difference (p ≤ 0.05) to erythrocytes from healthy individuals. 
 
IV. 1. 4. Forward Scatter of control and iron deficient erythrocytes: Infection of human 
erythrocytes with P. falciparum induces a biphasic change of the host erythrocyte volume. 
In the early trophozoite stage infected cells loose KCl and water leading to cell shrinkage. 
In the present study, ring-stage-synchronized erythrocytes when grown for 48h re-invaded 
and were in the early trophozoite stages. Accordingly, infected cells had a lower forward 
scatter than uninfected erythrocytes (Fig. 7). Noninfected and infected iron-deficient 
erythrocytes exhibited a lower forward scatter than uninfected and infected control 
erythrocytes, respectively (Fig. 7B), indicating lower cell volumes of the iron-deficient 
human erythrocytes. 
 
IV. 1. 5. In vivo clearance of fluorescence labelled erythrocytes: Further experiments have 
been performed to explore whether the reported enhanced phosphatidylserine exposure in 
erythrocytes from iron deficient mice leads to enhanced clearance of erythrocytes from 
circulating blood in vivo. To this end erythrocytes from iron-deficient and iron replete 
mice were labelled with the dye CFSE. As illustrated in Fig. 8, the decay of CFSE-labelled 
erythrocytes was significantly more rapid in iron deficient than in iron replete animals. 
Most importantly, the decline was particularly fast in infected CFSE-labelled erythrocytes 
as shown in Fig. 8B. Along those lines, the number of labelled erythrocytes recovered in 
the spleen was significantly enhanced in iron deficient animals (Fig. 8C). 
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Fig. 7: Effects of iron deficiency on forward scatter of infected and noninfected 
erythrocytes. 
A. Dot blots of forward scatter and syto16 fluorescence of human erythrocytes from 
healthy individuals (left panels) and iron deficient patients (right panels) prior to (upper 
panels) and 48 hours after (lower panel) infection with P. falciparum. 
B. Arithmetic means ± SEM (n = 8) of forward scatter of noninfected (left bars) and 
infected (right bars) erythrocytes from healthy individuals (open bars) or iron deficient 
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individuals (closed bars). * indicates significant difference (p ≤ 0.05) to erythrocytes from 
healthy individuals, # indicates significant difference between infected and noninfected 
erythrocytes. 
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Fig. 8: Clearance of erythrocytes from circulating blood. 
A: Arithmetic means ± SEM (n = 6) of the percentage of CFSE labelled non infected 
erythrocytes in circulating blood of iron deficient (closed symbols) or iron replete (open 
symbols) animals. * indicates significant difference (p ≤ 0.05) from iron replete animals. 
B: Arithmetic means ± SEM (n = 6) of the percentage of CFSE labelled erythrocytes 
infected with P. berghei in circulating blood of iron deficient (closed symbols) or iron 
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replete (open symbols) animals (33 % parasitemia each). * indicates significant difference 
(p<0.05) from iron replete animals. 
C: Abundance of CFSE labelled erythrocytes in spleens from iron replete (open bar) or 
iron deficient (closed bar) mice. Arithmetic means ± SEM (n = 6). * indicates significant 
difference (p<0.05) from iron replete animals. 
 
IV. 1. 6. In vivo proliferation of P. berghei in control and iron deficient mice: Further 
experiments have been performed to determine whether the effect of iron deficiency on 
survival of circulating erythrocytes would affect the course of malaria. To this end wild 
type mice were infected with P. berghei and the parasitemia monitored daily. As illustrated 
in Fig. 9, parasitized erythrocytes appeared in the circulating blood approximately 8 days 
after infection. In iron replete animals, the percentage of parasitized erythrocytes increased 
gradually up to 57 % within the following two weeks. The increase of parasitemia was 
significantly blunted in iron deficient animals (Fig. 9). 
 The effects of iron deficiency on the parasitemia were paralleled by enhanced 
survival of the infected mice. Whereas all iron replete animals died within 30 days after 
the infection, some 20 % of the iron-deficient animals survived the infection for more than 
30 days. Thus, iron deficiency indeed significantly modified the course of malaria. 
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Fig. 9: Parasitemia and survival of P.  berghei infected mice. 
A: Original histograms of parasitemia in iron replete animals (upper panels) and iron 
deficient animals (lower panels) 10 (left panels) and 20 (right panels) days after infection 
with P. berghei. 
B: Arithmetic means ± SEM (n = 6) of parasitemia in iron replete mice (open circles) or in 
iron deficient mice (closed circles) as a function of days after infection with P. berghei.          
* indicates significant difference (p ≤ 0.05) from iron replete animals. 
C: Survival of iron replete (open circles) or iron deficient (closed circles) mice as a 
function of days after infection with P. berghei. 
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IV. 1. 7. Haematological parameters: A mouse model of iron deficiency was 
accomplished by feeding the mice either a control diet containing 180 mg/Kg iron or a diet 
containing<10 mg/kg for 10 weeks. Indeed, dietary iron depletion led to the expected 
alterations of blood parameters, i.e.., increase of relative reticulocyte numbers, decrease of 
the mean corpuscular volume, decrease of the haemoglobin concentration and decrease of 
haematocrit in the peripheral blood of iron-deficient mice as compared with the respective 
control animals (Table 1).  
 
 Control Iron deficient P 
Erythrocytes 8.2 ± 0.3 8.3 ± 0.7 n.s 
Hematocrit 45 ± 2 36 ± 3 0.04 
MCV 49.9 ± 1.6 45.5 ± 0.5 0.03 
RTC 4.7 ± 0.1 6.6 ± 0.1 0.04 
HBG 21.7 ± 1.3 14.2 ± 1.6 0.01 
WBC 13.4± 1.1 12.8 ± 1.6 n.s. 
 
 
 
 
 
 
 
 
Table 1: Erythrocyte number (106/µl), packed cell volume (hematocrit, %), mean 
corpuscular volume (MCV, fl), reticulocyte count (RTC, %), hemoglobin (HBG, g/100 
ml), white blood cell count (WBC 1000/µl) in control and iron-deficient mice (all values 
arithmetic means ± SEM, n = 8). Erythrocyte and leukocyte counts were determined using 
MDM 905 (Medical Diagnostics Marx, Butzbach, Germany). Data are provided for control 
and iron-deficient mice. The P value indicates significant difference between control and 
iron deficient mice;    n. s. is not significantly different. 
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IV. 2. Impact of NO synthase inhibitior L-NAME on the course of malaria 
 
IV. 2. 1. Annexin binding of noninfected and infected erythrocytes of control and            
L-NAME treated erythrocytes: To elucidate, whether inhibition of NO synthase or 
infection with P.  falciparum modifies the percentage of cells exposing phosphatidylserine 
at the cell surface, we determined annexin binding in FACS analysis. The percentage of 
annexin-positive erythrocytes in freshly drawn human blood was low (1.7 ± 0.2 %, n = 8). 
A 24 hour incubation in Ringer solution increased the percentage of annexin binding cells 
to (4.5 ± 0.2 %, n = 8), a 48 hour incubation in Ringer solution increased the percentage of 
annexin binding noninfected erythrocytes to (17 ± 1 %, n = 10). As illustrated in Fig. 10, 
infection significantly enhanced the percentage of annexin binding erythrocytes. The 
presence of L-NAME significantly increased the percentage of annexin binding 
erythrocytes (Fig. 10B). 
 
IV. 2. 2. In vitro growth of P.  falciparum in erythrocytes of control and L-NAME 
treated erythrocytes:  L-NAME did not significqntly modify the DNA/RNA amplification 
or the in vitro percentage of infected erythrocytes. Thus, L-NAME did apparently not 
influence the intraerythrocytic growth of the pathogen and the in vitro infection of 
erythrocytes (Fig. 11). 
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Fig. 10: Effects of NO-synthase inhibitor L-NAME on phosphatidylserine exposure of 
infected and noninfected erythrocytes. 
A. Dot blots of annexin binding and Syto16 fluorescence of human erythrocytes in 
noninfected cells (upper panels) and in cells infected with P.  falciparum (lower panels) 
following a 48 hours incubation in the absence (left panels), or presence (right panels) of 
10 µM  L-NAME. 
B. Arithmetic means ± SEM (n = 6) of annexin binding of infected (closed symbols) and 
noninfected (open symbols) erythrocytes as a function of L-NAME concentration 
(arithmetic means ± SEM, n = 6). * indicates significant difference (p ≤ 0.05) from control, 
# indicates significant difference to noninfected erythrocytes. 
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Fig. 11: Effects of NO-synthase inhibitor L-NAME on parasite growth. 
A. Intraerythrocytic DNA amplification in erythrocytes as a function of L-NAME 
concentration (arithmetic means ± SEM, n = 8-10). 
B. In vitro growth of P.  falciparum in human erythrocytes as a function of L-NAME 
concentration (arithmetic means ± SEM, n = 8-10). 
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IV. 2. 3. Forward Scatter of control and L-NAME treated erythrocytes: The effect of     
L-NAME on phosphatidylserine exposure was paralleled by a decrease of forward scatter 
of both infected and noninfected erythrocytes (Fig. 12). 
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Fig. 12: Effects of L-NAME on forward scatter of infected and noninfected 
erythrocytes.  
A. Dot blots of forward scatter and syto16 fluorescence of human erythrocytes in 
noninfected cells (upper panels) and in cells infected with P.  falciparum (lower panels) 
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following a 48 hours incubation in the absence (left panels), or presence (right panels) of 
10 µM  L-NAME. 
B. Arithmetic means ± SEM (n = 6) of forward scatter of infected (closed symbols) and 
noninfected (open symbols) erythrocytes before and after treatment with L-NAME, as a 
function of L-NAME concentration (arithmetic means ± SEM, n = 6). * indicates 
significant difference (p ≤ 0.05) from control, # indicates significant difference to 
noninfected erythrocytes. 
 
IV. 2. 4. In vivo clearance of fluorescence labelled erythrocytes: Further experiments have 
been performed to explore whether the enhanced phosphatidylserine exposure leads to 
enhanced clearance of erythrocytes from circulating blood in vivo. To this end erythrocytes 
have been labelled with the dye CFSE and were injected into the tail vein of untreated and 
L-NAME treated mice. As illustrated in Fig. 13A, clearance of erythrocytes was 
significantly faster in L-NAME treated mice than in untreated animals. Conversely, the 
number of labelled erythrocytes recovered in the spleen was significantly enhanced by L-
NAME treatment (Fig. 13B). 
 As illustrated in Fig. 13C, only a small portion of labelled infected erythrocytes 
were cleared within 120 minutes in untreated mice, but a significantly larger percentage of 
labelled infected erythrocytes disappeared within 120 minutes after injection in L-NAME 
treated mice. Conversely, the number of labelled erythrocytes recovered in the spleen was 
significantly enhanced by L-NAME treatment (Fig. 13D). 
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Fig. 13: Clearance of erythrocytes from circulating blood of noninfected and infected 
mice. 
Disappearance of CFSE-labelled erythrocytes from circulating blood following injection 
into the tail vein of untreated and L-NAME treated mice (1mg/ml in drinking water). 
A: Arithmetic means ± SEM (n = 8) of the percentage of CFSE-labelled noninfected 
erythrocytes in circulating blood of control mice (open symbols) and L-NAME treated 
mice (closed symbols). * indicates significant difference (p ≤ 0.05) from control mice. 
B: Abundance of CFSE-labelled noninfected erythrocytes in spleen of untreated (open bar) 
and L-NAME treated (closed bar) mice. Arithmetic means ± SEM (n = 8). * indicates 
significant difference (p ≤ 0.05) from control mice. 
C: Arithmetic means ± SEM (n = 6) of the percentage of CFSE-labelled infected 
erythrocytes in control mice (open symbols) and L-NAME treated mice (closed symbols). 
* indicates significant difference (p ≤ 0.05) from control mice. 
D: Abundance of CFSE-labelled infected erythrocytes in spleen of untreated (open bar) 
and L-NAME treated (closed bar) mice. Arithmetic means ± SEM (n = 6). * indicates 
significant difference (p ≤ 0.05) from control mice. 
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IV. 2. 5. In vivo proliferation of P. berghei in control and L-NAME treated mice: 
Further experiments have been performed to determine whether the effect of L-NAME on 
phosphatidylserine exposure and survival of circulating erythrocytes would affect the 
course of malaria. To this end, wild type mice were infected with P. berghei and the 
parasitemia monitored daily. As illustrated in Fig. 14, parasitized erythrocytes appeared in 
the circulating blood approximately 8 days after infection. In untreated animals, the 
percentage of parasitized erythrocytes increased gradually up to 53% within the following 
two weeks. In contrast, the addition of L-NAME (1 mg/ml) to the drinking water 
significantly blunted the increase of parasitemia (up to 21%). Thus, L-NAME treatment 
indeed significantly modified the increase of parasitemia. The favourable influence of L-
NAME on parasitemia was, however, not paralleled by significantly enhanced survival of 
infected animals. 
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Fig. 14: Parasitemia and survival of P.  berghei infected mice. 
A: Original histograms of parasitemia in untreated animals (upper panels) and animals 
treated from day 10 until day 20 with L-NAME (1mg/ml in drinking water, lower panels) 
10 (left panels) and 20 (right panels) days after infection with P.  berghei. 
B: Arithmetic means ± SEM (n = 15-21) of parasitemia in mice without treatment (open 
circles) or treated with L-NAME (closed circles) as a function of days after infection with 
P.  berghei. 
C: Survival of mice without treatment (open circles) or treated with L-NAME (closed 
circles) as a function of days after infection with P.  berghei. 
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IV. 3. Influence of lead treatment on P.  berghei infected mice 
 
IV. 3. 1. Annexin binding of noninfected and infected control and lead treated 
erythrocytes: To elucidate, whether Pb(NO3)2 and/or infection with P. falciparum 
modifies the percentage of cells exposing phosphatidylserine at the cell surface, we 
determined annexin binding in FACS analysis. The percentage of annexin-positive 
erythrocytes in freshly drawn blood was low (1.5 ± 0.1 %, n = 8). A 24 hour incubation in 
Ringer solution increased the percentage of annexin binding cells to (5.9 ± 0.1 %, (n = 8), 
a 48 hour incubation in Ringer solution increased the percentage of annexin binding of 
noninfected erythrocytes to 13.7 ± 2.8 % (n =  8). As illustrated in Fig. 15, infection 
significantly enhanced the percentage of annexin binding erythrocytes. The presence of 
Pb(NO3)2 significantly increased the percentage of annexin binding erythrocytes. The 
effect was particularly prominent in infected erythrocytes (Fig. 15B). Thus, Pb(NO3)2  
preferably triggered phosphatidylserine exposure of infected cells.  
IV. 3. 2. Fluorescence staining and flourescence microscopy: The Pb2+-stimulated 
phosphatidylserine exposure of the erythrocytes was confirmed using immunofluorescence 
microscopy (Fig. 16), further demonstrating that phosphatidylserine exposure was 
accompanied by a change in erythrocyte morphology. Exposure to Pb2+ stimulated the 
transition from the biconcave to an echinocyte morphology suggesting Pb2+-induced 
erythrocyte shrinkage. 
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Fig. 15: Effects of Pb(NO3)2 on phosphatidylserine exposure of infected and 
noninfected erythrocytes. 
A. Dot blots of annexin binding and Syto16 fluorescence of human erythrocytes in 
noninfected cells (upper panels) and in cells infected with P.  falciparum (lower panels) 
following a 48 hours incubation in the absence (left panels), or presence (right panels) of 
10 µM Pb2+ (Pb(NO3)2). 
B. Arithmetic means ± SEM of annexin binding of infected (closed symbols) and 
noninfected (open symbols) erythrocytes treated with lead as a function of the Pb2+ 
concentration (arithmetic means ± SEM, n = 8). * indicates significant difference (p ≤ 
0.05) from absence of Pb2+, # indicates significant difference to noninfected erythrocytes.  
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Fig. 16: Erythrocyte shrinkage after exposure to Pb+ ions.  
Light transmission (top) and fluorescence (annexin-V-fluos) photomicrographs (bottom) of 
erythrocytes exposed for 24 h at 37°C to Pb2+. Binding of annexin-V-fluos is accompanied 
by a change from biconcave to echinocyte erythrocyte morphology. 
 
IV. 3. 3. Forward Scatter of control and lead treated erythrocytes: The effect of 
Pb(NO3)2 on phosphatidylserine exposure was paralleled by a decrease of forward scatter 
of both infected and noninfected erythrocytes reflecting a decrease of cell volume        
(Fig. 17). 
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Fig. 17: Effects of Pb(NO3)2 on forward scatter of infected and noninfected 
erythrocytes.  
A. Dot blots of forward scatter and Syto16 fluorescence of human erythrocytes in 
noninfected cells (upper panels) and in cells infected with P.  falciparum (lower panels) 
following a 48 hours incubation in the absence (left panels), or presence (right panels) of 
10 µM Pb2+ (Pb(NO3)2). 
B. Arithmetic means ± SEM (n=8) of forward scatter of infected (closed symbols) and 
noninfected (open symbols) erythrocytes treated with lead as a function of the Pb2+ 
concentration (arithmetic means ± SEM, n = 8). * indicates significant difference             
(p ≤ 0.05) from absence of Pb2+, # indicates significant difference from noninfected 
erythrocytes.  
 
IV. 3. 4. Intracellular Ca2+  influx in control and lead treated erythrocytes: Reportedly, 
erythrocyte shrinkage induces activation of Ca2+-permeable nonselective cation channels 
[Huber et al., 2001]. Thus erythrocytes were loaded with the Ca2+-sensitive fluorescence 
dye fluo-3 (2 µM fluo-3 AM) to determine the effect of Pb2+ on cytosolic Ca2+ activity. 
Cells were incubated in the absence or presence of  Pb2+ (1 µM for 30 min) or the Ca2+ 
ionophore ionomycin (1 µM), and fluo-3 fluorescence intensity was monitored using 
FACS. As illustrated in Fig. 18, Pb2+ indeed increased fluo-3 fluorescence intensity. As a 
positive control, the Ca2+ ionophore ionomycin (1 µM) similarly enhanced the fluo-3 
 56 
fluorescence intensity (Fig. 18B). The data strongly suggest that the observed Pb2+ effect 
on fluo-3-loaded erythrocytes indeed reflect an increase in cytosolic free Ca2+ 
concentration. 
 
                       
 
 
Fig. 18: Pb2+-induced increase in cytosolic free Ca2+ concentration.  
A: Fluorescence-activated cell sorting (FACS) histograms showing the Ca2+-sensitive 
fluorescence of fluo-3-loaded erythrocytes incubated in NaCl-Ringer solution (control), in 
NaCl-Ringer solution containing 1 µM Pb2+ (Pb2+), or in NaCl-Ringer solution containing 
1 µM Ca2+ ionophore ionomycin (iono).  
B: Mean fluo-3 fluorescence (arithmetic means ± SE; n = 6) of erythrocytes incubated as 
in A either in Ringer solution (R) or in Ringer solution containing Pb2+ (1 µM; 20-min 
incubation) or ionomycin (1 µM; 5-min incubation).  
 
IV. 3. 5. In vitro growth of P. falciparum in erythrocytes of control and lead treated 
erythrocytes: Lead did not significantly modify the DNA/RNA content or the in vitro 
percentage of infected erythrocytes. Thus, lead did not apparently influence the 
intraerythrocytic growth of the pathogen and the in vitro infection of erythrocytes        
(Fig. 19). 
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Fig. 19: Effects of Pb(NO3)2 on parasite growth. 
A. Intraerythrocytic DNA amplification in erythrocytes as a function of the Pb2+ 
concentration (arithmetic means ± SEM, n = 8-10).  
B. In vitro growth of P. falciparum in human erythrocytes as a function of Pb2+ 
concentration (arithmetic means ± SEM, n = 8-10).  
 
 
IV. 3. 6. In vivo clearance of fluorescence labelled erythrocytes: Further experiments 
were performed to explore whether the enhanced phosphatidylserine exposure leads to 
enhanced clearance of erythrocytes from circulating blood in vivo. To this end, 
erythrocytes were either left untreated or treated with 10 µM Pb(NO3)2 and were labelled 
with the dye CFSE. As illustrated in Fig. 20, the clearance of labelled untreated 
erythrocytes was slow but significantly accelerated by prior treatment of the labelled 
erythrocytes with Pb(NO3)2. Along those lines, the number of labelled erythrocytes 
recovered in the spleen was significantly enhanced by Pb(NO3)2 treatment. 
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A) B)  
  
 
 
 
 
 
 
Fig. 20: Clearance of Pb(NO3)2 treated erythrocytes from circulating blood. 
A: Disappearance of untreated and Pb(NO3)2 treated CFSE-labelled erythrocytes from 
circulating blood following injection into the tail vein. Arithmetic means ± SEM (n = 6) of 
the percentage CFSE-labelled untreated (open symbols) or Pb(NO3)2 treated (closed 
symbols) erythrocytes after injection. * indicates significant difference from the untreated 
erythrocytes. 
B: Abundance of CFSE-labelled untreated (open bar) or Pb(NO3)2 treated (closed bar) 
erythrocytes in spleen. Arithmetic means ± SEM (n =6). * indicates significant difference 
from the untreated erythrocytes. 
 
IV. 3. 7. In vivo proliferation of P. berghei in control and lead treated mice: Further 
experiments were performed to determine whether the effect of lead on phosphatidylserine 
exposure and survival of circulating erythrocytes would affect the course of malaria. To 
this end, wild type mice were infected with P. berghei and the parasitemia monitored 
daily. As illustrated in Fig. 21, parasitized erythrocytes appeared in the circulating blood 
approximately 8 days after infection. In untreated animals, the percentage of parasitized 
erythrocytes increased gradually up to 52% within the following two weeks.  The addition 
of 100 µM Pb(NO3)2 to the drinking water significantly blunted the increase of 
parasitemia. The effects of Pb(NO3)2 on the parasitemia was paralleled by enhanced 
survival of the Pb(NO3)2 treated animals. Whereas all nontreated animals died within 30 
days after the infection, approximately 38% of the lead treated animals survived the 
infection for more than 30 days (Fig. 21C). Thus, lead treatment indeed significantly 
modified the course of malaria. 
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Fig. 21: Parasitemia and survival of P.  berghei infected mice. 
A: Original histograms of parasitemia in untreated animals (upper panels) and animals 
treated from day 10 until day 20 with 100 µM Pb(NO3)2 (lower panels) 10 (left panels) and 
20 (right panels) days after infection with P. berghei.  
 60 
B: Arithmetic means ± SEM (n = 12) of parasitemia in mice without treatment (open 
circles) or with 100 µM Pb(NO3)2 (closed circles) as a function of days after infection with 
P.  berghei. * indicates significant difference from the untreated animals. 
C: Survival of mice without treatment (open circles) or treated with 100 µM Pb(NO3)2 
(closed squares) as a function of days after infection with P.  berghei. 
 
IV. 3. 8. Haematological parameters: To explore the toxicity of the Pb(NO3)2 treatment, 
the blood count has been analysed in noninfected mice treated with 100µM Pb(NO3)2. As 
listed in table 2, the lead treatment was followed by a slight decrease of erythrocyte 
number, hematocrit and haemoglobin concentration. 
 
 control 10 days 20 days 30 days 
Erythrocytes 9.25 ± 0.10 9.35 ± 0.02 9.32 ± 0.5 9.05 ± 0.27 
Hematocrit 45.07 ± 0.60 44.05 ± 1.34 44.2 ± 3 40.87 ± 1.59
MCV 48.27 ± 0.42 47.12 ± 0.59 47.27 ± 0.83 45.07 ± 0.65*
RTC 1.29 ± 0.15 1.35 ± 0.19 1.89 ± 0.32 3.33 ± 0.34*
HBG 23.11 ± 0.75 22.36 ± 1.2 21.43 ± 0.7 21.58 ± 0.76
WBC 10.36 ± 0.64 10.01 ± 0.57 9.9 ± 0.8 11.18 ± 1.64
 
Table 2: Erythrocyte number (106/µl), packed cell volume (hematocrit, %), mean 
corpuscular volume (fl), reticulocyte count (RTC, %), , hemoglobin (HBG, g/100 ml), 
white blood cell count (WBC 1000/µl) in mice prior to (control) and following a 10, 20 or 
30 days treatment with 100 µM Pb(NO3)2  (all values arithmetic means ± SEM, n = 6). 
Erythrocyte and leukocyte counts were determined using MDM 905 (Medical Diagnostics 
Marx, Butzbach, Germany). * indicates significant difference from the control animals. 
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IV. 4. Influence of chlorpromazine on the course of malaria 
 
IV. 4. 1. Annexin binding of noninfected and infected control and chlorpromazine 
treated erythrocytes: Phosphatidylserine at the cell surface was estimated from annexin V 
binding in FACS analysis. The percentage of annexin-binding erythrocytes in freshly 
drawn blood was low 1.48 ± 0.05 %, n=6). A 24 hour incubation in Ringer solution 
increased the percentage of annexin binding cells to 5.28 ± 0.29 % (n=6), a 48 hour 
incubation in Ringer solution increased the percentage of annexin binding noninfected 
erythrocytes to 14.93 ± 0.39 % (n=6), As shown in Fig. 22, infection significantly 
enhanced the percentage of annexin binding erythrocytes. The effect of infection was 
significantly enhanced in the presence of chlorpromazine (Fig. 22B). The effect reached 
statistical significance at 10 µM chlorpromazine. Thus, chlorpromazine potentiated the 
scrambling effect of infection on phosphatidylserine exposure. 
 
IV. 4. 2. In vitro growth of P. falciparum in control and chlorpromazine treated 
erythrocytes: Intraerythrocytic DNA amplification in erythrocytes was not significantly 
influenced by chlorpromazine at the concentrations employed. In vitro growth of              
P. falciparum in human erythrocytes was, however, significantly decreased at 
chlorpromazine concentrations ≥ 5 µM (Fig. 23). 
 
 
 
 
 
 
 
 
 
 
 
 
 62 
 A) 
100 101 102 103 104
102
104
101
103
100
100 101 102 103 104
102
104
101
103
100
100 101 102 103 104
0 µM Chlorpromazine 10 µM Chlorpromazine
An
ne
xi
n
V 
flu
or
es
ce
nc
e
[r
el
. u
ni
ts
]
Syto 16 fluorescence [rel.units]
102
104
101
103
100
102
104
101
103
100
100 101 102 103 104
An
ne
xi
n
V 
flu
or
es
ce
nc
e
[r
el
. u
ni
ts
]
An
ne
xi
n
V 
flu
or
es
ce
nc
e
[r
el
. u
ni
ts
]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*
0
10
20
30
40
50
60
70
80
90
100
0 0.1 1 10 10
Chlorpromazine (µM)
A
nn
ex
in
bi
nd
in
g
(%
)
* *
#
# # #
*#
*#
*#
0
A
nn
ex
in
bi
nd
in
g
(%
)B) 
 
 
 
 
 
 
 
 
 
Fig. 22: Effects of Chlorpromazine on phosphatidylserine exposure of infected and 
noninfected erythrocytes. 
A. Dot blots of annexin binding and Syto16 fluorescence of human erythrocytes in 
noninfected cells (upper panels) and in cells infected with P.  falciparum (lower panels) 
following a 48 hours incubation in the absence (left panels), or presence (right panels) of 
10 µM chlorpromazine. 
B. Arithmetic means ± SEM (n=6) of annexin binding of infected (closed symbols) and 
noninfected (open symbols) erythrocytes as a function of the chlorpromazine 
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concentration. * indicates significant difference (p<0.05) from absence of chlorpromazine, 
# indicates significant difference from noninfected erythrocytes.  
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Fig. 23: Effects of chlorpromazine on parasite growth. 
A. Intraerythrocytic DNA amplification in erythrocytes as a function of the 
chlorpromazine concentration (arithmetic means ± SEM, n=6).  
B. In vitro growth of P.  falciparum in human erythrocytes as a function of chlorpromazine 
concentration (arithmetic means ± SEM, n=6). * indicates significant difference (p<0.05) 
from absence of chlorpromazine. 
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IV. 4. 3. Forward scatter of control and chlorpromazine treated erythrocytes: Infection 
further decreased erythrocyte forward scatter. Chlorpromazine led to a moderate but 
significant further decrease of forward scatter, pointing to chlorpromazine induced cell 
shrinkage (Fig. 24). 
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Fig. 24: Effects of chlorpromazine on forward scatter of infected and noninfected 
erythrocytes.  
A. Dot blots of forward scatter and syto16 fluorescence of human erythrocytes in 
noninfected cells (upper panels) and in cells infected with P.  falciparum (lower panels) 
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following a 48 hours incubation in the absence (left panels), or presence (right panels) of 
10 µM chlorpromazine. 
B. Arithmetic means ± SEM (n=6) of forward scatter of infected (closed symbols) and 
noninfected (open symbols) erythrocytes as a function of the chlorpromazine 
concentration. * indicates significant difference (p<0.05) from absence of chlorpromazine, 
# indicates significant difference to noninfected erythrocytes.  
 
IV. 4. 4. Clearance of chlorpromazine treated erythrocytes from circulating blood:  A 
next series of experiments explored, whether the enhanced phosphatidylserine exposure 
accelerates clearance of erythrocytes from circulating blood in vivo. For this purpose mice 
were either left untreated or treated with 100 µM chlorpromazine in drinking water, their 
erythrocytes were labelled with the dye CFSE and injected into the tail vein. As illustrated 
in Fig. 25B, the clearance of erythrocytes in chlorpromazine treated mice was slightly, but 
significantly faster than erythrocyte clearance in untreated mice. Most importantly, the 
decline was particularly fast in infected CFSE-labelled erythrocytes (Fig. 25B). On the 
other hand, the fraction of labelled erythrocytes recovered in the spleen was significantly 
enhanced by chlorpromazine treatment (Fig. 25C). 
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Fig. 25: Clearance of chlorpromazine treated erythrocytes from circulating blood. 
Disappearance of CFSE-labelled noninfected and infected erythrocytes from circulating 
blood following injection into the tail vein of untreated and chlorpromazine treated (100 
µM) mice in drinking water. 
A: Arithmetic means ± SEM (n = 6) of the percentage of CFSE-labelled noninfected 
erythrocytes in circulating blood of untreated (open symbols) or chlorpromazine (open 
symbols) treated animals. * indicates significant difference (p<0.05) from untreated 
animals.  
B: Arithmetic means ± SEM (n=6) of the percentage CFSE labelled infected erythrocytes 
in circulating blood of untreated (open symbols) or chlorpromazine treated (closed 
symbols) animals. * indicates significant difference from the untreated animals. 
C: Abundance of CFSE-labelled untreated (open bar) or chlorpromazine treated (closed 
bar) erythrocytes in spleen. Arithmetic means ± SEM (n=6). * indicates significant 
difference from the untreated animals. 
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IV. 4. 5. In vivo proliferation of P. berghei in control and chlorpromazine treated 
mice: Further experiments were performed on the impact of chlorpromazine treatment on 
the course of malaria infection in vivo. To this end mice were infected with P.  berghei. As 
shown in Fig. 26, parasitemia was less than 10% 8 days after infection but gradually 
increased the next 14 days. In untreated animals, the percentage of parasitized erythrocytes 
increased up to 48%. The addition of 100 µM chlorpromazine had only a slight effect on 
parasitemia (data not shown). Thus, the concentration of chlorpromazine was increased to 
1 mM chlorpromazine, which indeed significantly blunted the increase of parasitemia. 
  
The effect of chlorpromazine on the parasitemia was paralleled by enhanced 
survival of the chlorpromazine treated animals. Whereas all untreated animals died within 
25 days after the infection, 80% of the chlorpromazine treated animals survived the 
infection for more than 30 days (Fig. 26C). Thus, chlorpromazine treatment indeed 
significantly modified the course of malaria.  
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Fig. 26: Parasitemia and survival of P.  berghei infected mice. 
A: Original histograms of parasitemia in untreated animals (upper panels) and animals 
treated from day 10 until day 19 with 1 mM chlorpromazine (lower panels) 10 (left panels) 
and 19 (right panels) days after infection with P.  berghei.  
B: Arithmetic means ± SEM (n=10-11) of parasitemia in mice without treatment (open 
circles) or with 1 mM chlorpromazine (closed circles) as a function of days after infection 
with P.  berghei. * indicates significant difference from the untreated animals. 
C: Survival of mice without treatment (open circles) or with 1 mM chlorpromazine (closed 
circles) as a function of days after infection with P.  berghei. 
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V.   DISCUSSION 
 
      Our observations indicate that Plasmodium infected eryhtrocytes can be targeted for 
induction of eryptosis in vivo. This acclerated eryptosis of Plasmodium-infected RBCs results 
in rapid clearance of infected erythrocytes and confer protection against severe course of 
malaria. Plasmodium imposes oxidative stress to the host cell [Duranton et al., 2003; 
Duranton et al., 2004; Huber et al., 2002; Huber et al., 2004] leading to cation channel 
activiation [Duranton et al., 2004; Huber et al., 2002; Huber et al., 2004] and Ca2+ entry 
[Duranton et al., 2004]. Thus, infection was expected to trigger phosphatidylserine exposure. 
Infection of erythrocytes with Plasmodium was indeed found to triggers eryptosis [Brand et 
al., 2003]. If the stimulation of eryptosis remains anabated, it may proceed too fast for the 
pathogen to allow intraerythrocytic maturation. It has been observed that accelerated aging or 
eryptosis of Plasmodium-infected erythrocytes in sickle-cell trait, beta-thalassemia-trait, 
homozygous Hb-C and G6PD-deficiency leads to the clearance of ring stage-infected 
erythrocytes and has thus been attributed to the partial malaria resistance conferred by 
these genetic disorders [Ayi et al., 2004; Cappadoro et al., 1998; de Jong et al., 2001; Kean 
et al., 2002; Kuypers et al., 1998; Lang et al., 2002a]. Early clearance of infected 
erythrocytes prevents on the one hand tissue sequestration of the late stage-infected 
erythrocytes and on the other hand hemozoin-intoxication of trophozoite-engulfing 
macrophages which impairs macrophage function [Schwarzer et al., 1992].  
                   
 The manipulation of eryptosis of the Plasmodium-infected erythrocytes by diet 
modifications or pharmacological interventions may provide some protection during 
malaria. Therefore, we have chosen to study the influence of iron deficiency, NO synthase 
inhibition, Pb(NO3)2 and chlorpromazine on eryptosis, parasitemia and survival during the 
course of malraia. 
 
V. 1.  Influence of iron deficiency on the course of malaria  
        The present studies clearly demonstrate that iron deficiency confers some protection 
following infection with the malaria pathogen P. berghei. Moreover, they provide 
evidence that the protection correlates with accelerated clearance of infected erythrocytes 
from circulating blood. As shown previously [Kempe et al. 2006], iron deficiency leads to 
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activation of non-selective cation channels with subsequent Ca2+ entry and increase of 
cytosolic Ca2+ activity. Moreover, calcium uptake into the red blood cells was shown to be 
markedly enhanced in patients with iron deficiency [Shimoda and Yawata 1985]. The 
increase of cytosolic Ca2+ activity in turn leads to scrambling of the erythrocyte cell 
membrane [Dekkers et al., 2002; Woon et al., 1999], which is enhanced in iron deficient 
erythrocytes [Kempe et al. 2006]. The breakdown of phosphatidylserine asymmetry leads to 
exposure of phosphatidylserine at the erythrocyte surface and subsequent binding to 
phosphatidylserine receptors at macrophages [Fadok et al., 2000; Henson et al., 2001; 
Messmer and Pfeilschifter 2000]. The enhanced phosphatidylserine exposure may further 
allow adhesion of erythrocytes to endothelial cells [Boas et al., 1998; Eda and Sherman 
2002]. This adhesion may impede the microcirculation and it is thus tempting to speculate 
that it participates in the generation of ischemic complications of iron deficiency [Hartfield 
et al., 1997; Pereira and Sarnak 2003]. 
  
The enhanced susceptibility of iron deficient erythrocytes to eryptosis may relate to 
altered cell volume regulation. The reduced hemoglobin content may decrease the colloid 
osmotic pressure and thus cell volume [Schwarzer et al., 1992]. Since the non-selective 
cation channel is activated by cell shrinkage [Huber et al., 2001], the decreased cell volume 
could account for the enhanced activity of the channel. Entry of Na+ through this channel 
serves to increase cell volume, the entry of Ca2+, however, activates the Ca2+ sensitive K+ 
channel (GARDOS channel) [Bookchin et al., 1987; Brugnara et al., 1993]. The subsequent 
hyperpolarisation of the cell membrane drives Cl- out of the cell and the cellular loss of KCl 
with osmotically obliged water leads to subsequent further cell shrinkage.  
 
In addition, iron deficient erythrocytes are more sensitive to oxidative stress 
[Ramachandran and Iyer 1984; Vives Corrons et al., 1995], which similarly activates the 
cation channel [Duranton et al., 2003; Lang et al., 2002b; Lang et al., 2003a]. The cellular 
loss of K+ through the GARDOS channel contributes to the stimulation of eryptosis [Lang et 
al., 2003d]. Loss of cellular K+ may participate in the triggering of apoptosis in several cell 
types [Bortner et al., 1997; Bortner and Cidlowski 1999; Gomez-Angelats et al., 2000; 
Hughes, Jr. et al., 1997; Hughes, Jr. and Cidlowski 1999; Montague et al., 1999; Perez et 
al., 2000]. Activation of Ca2+ sensitive K+ channels similarly participates in the cell 
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shrinkage and deformation of desoxygenized sickle cells [Bookchin et al., 1987; Brugnara 
et al., 1993; Franco et al., 1996; Joiner 1993; Lew and Bookchin 1991]. 
  
 While accelerated eryptosis and clearance of infected erythrocytes provides an 
explanation for the slower increase of parasitemia in iron deficiency, the in vitro decrease 
of intraerythrocytic growth and the in vitro decrease of infected erythrocytes do point to 
additional mechanisms involved in the decreased parasitemia of iron deficient 
erythrocytes. Thus, accelerated clearance of infected erythrocytes contributes to but does 
presumably not fully account for the decreased parasitemia. Iron deficiency enhances the 
susceptibility of eythrocytes to eryptosis. As a result, iron deficient erythrocytes undergo 
accelerated eryptosis following infection with Plasmodium and are thus rapidly cleared from 
circulating blood together with the pathogen. The accelerated eryptosis precedes the full 
intraerythrocytic maturation of the pathogen and thus blunts the increase of parasitemia. 
Beyond that iron deficiency impairs intraerythrocytic growth and infection of erythrocytes. 
 
V. 2.  Impact of NO synthase inhibitor L-NAME on the course of malaria  
         As reported previously [Nicolay et al., 2007], NO is a potent inhibitor of eryptosis. 
Thus, inhibition of NO synthase is expected to favour or accelerate eryptosis. Accordingly, 
the NO synthase inhibitor L-NAME triggers Ca2+ sensitive cell membrane scrambling with 
subsequent exposure of phosphatidylserine at the erythrocytes surface. The treatment of 
mice with L-NAME accelerated the clearance of erythrocytes from circulating blood. The 
majority of cleared labelled cells were accumulated in the spleen. L-NAME treatment 
delayed the development of parasitemia. 
  
 The antieryptotic effect of NO donators was mimicked by di-butyryl-cGMP [Nicolay 
et al., 2007], suggesting the involvement of guanylate cyclase, cGMP and protein kinase 
G, a well known signalling pathway of NO action [Feil et al., 2003; Fleming et al., 1999; 
Friebe and Koesling 2003; Geng et al., 1998; Klein 2002; McHugh and Cheek 1998; 
Munzel et al., 2005; Pohl and Busse 1989; Schlossmann et al., 2003]. cGMP stimulates the 
Ca2+ ATPase [Dedkova and Blatter 2002; Ogurusu et al., 1990; Rashatwar et al., 1987; 
Uneyama et al., 1998; Vrolix et al., 1988], which contributes to the regulation of 
erythrocyte Ca2+ concentration [Davis et al., 1982; Xu and Roufogalis 1988]. However, 
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NO donators did not appreciably decrease cytosolic Ca2+ activity [Nicolay et al., 2007] and 
may thus be effective through other signalling pathways. In nucleated cells the 
antiapoptotic effect of NO is in part due to inhibition of caspases [Dimmeler et al., 1997; 
Rossig et al., 1999]. However, caspases are apparently not involved in the triggering of 
eryptosis following increase of cytosolic Ca2+ activity [Lang et al., 2003a]. Presumably, 
NO is effective through nitrosylation [Benhar and Stamler 2005; Haendeler et al., 2002; 
Haendeler et al., 2004; Hoffmann et al., 2001b; Melino et al., 1997] of enzymes necessary 
for induction of cell membrane scrambling [Nicolay et al., 2007]. 
   
 Despite its favourable influence on the development of parasitemia, L-NAME 
treatment did not significantly decrease or delay the death rate of Plasmodium infected mice. 
Impaired NO formation leads to hypertension, peripheral ischemia and organ damage, which 
presumably outweighs the decerease of parasitemia. Thus, due to those severe side effects, 
inhibition of NO synthase is apparently not a therapeutic option in the treatment of malaria.  
 
V. 3.  Influence of lead treatment on the course of malaria 
          The treatment with Pb(NO3)2 has previously been shown [Kempe et al., 2005] to 
stimulate Ca2+ activated charybdotoxin and clotrimazol sensitive K+ channels [Bookchin et 
al., 1987; Brugnara et al., 1993] resulting in erthrocyte shrinkage [Lang et al., 2003b]. 
Moreover, the activated cation channels may allow the entry of Pb(NO3)2  thus enhancing the 
toxicity of Pb(NO3)2 treatment in infected cells. Pb(NO3)2  treatment triggers Ca2+ sensitive 
cell membrane scrambling with subsequent exposure of phosphatidylserine at the 
erythrocytes surface. 
  
 The treatment with lead significantly decreased the development of in vivo parasitemia. 
The effect is presumably due to premature phosphatidylserine exposure of infected cells. In 
vitro, phoshpatidylserine exposure does not lead to sequestration and clearance of 
erythrocytes and thus does not significantly modify the increase of parasitemia. Pb(NO3)2 
treated phosphatidylserine exposing erythrocytes are rapidly cleared from circulating blood. 
The majority of cleared labelled cells were accumulated in the spleen (Fig. 20). Decreased in 
vivo parasitemia following lead treatment may be expected to affect the survival of infected 
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animals. Similar to previous series [Huber et al., 2004], none of the untreated mice survived 
the infection with P. berghei (Fig. 21). In contrast, some 38 % of the Pb(NO3)2  treated 
mice were still alive 30 days after the infection illustrating that Pb(NO3)2  treatment indeed 
favourably modifies the course of malaria.  
  
 Considering the toxicity of lead, sequelae of lead intoxication include anaemia which 
is partially due to shortened life span of circulating erythrocytes [Osterode et al., 1999]. Lead 
ions adhere to erythrocyte cell membranes [Suwalsky et al., 2003], decrease the erythrocyte 
ATP concentration [Baranowska-Bosiacka and Hlynczak 2003; Grabowska and Guminska 
1996], delay the decline of protoporphyrin concentration in mature erythrocytes [Lamola et 
al., 1975; Piomelli et al., 1975], and decrease 5´ nucleotidase activity [Valentine et al., 1976].  
  
 In conclusion, Pb(NO3)2  treatment may lead to slight anaemia, but is protective 
against a lethal course of malaria infection. We speculate that a similar mechanism confers 
protection against a severe course of malaria in carriers of the sickle cell anaemia trait. The 
observations may not only serve to understand the mechanisms of host defence against the 
malaria pathogen but open new perspectives for the treatment of malaria. 
 
V.4. Influence of chlorpromazine on the course of malaria 
           The present experiments confirm the ability of chlorpromazine at therapeutical 
concentrations [Dorson and Crismon 1988] to induce eryptosis [Akel et al., 2006]. The 
ability of chlorpromazine to trigger scrambling of the cell membrane is shared by several 
amphiphiles [Hagerstrand et al., 1998; Rosso et al., 1988; Schneider et al., 1986; Schrier et 
al., 1983; Schrier et al., 1986; Schrier et al., 1992]. Chlorpromazine further decreased 
forward scatter pointing to cell shrinkage, which was presumably due to increase of 
cytosolic Ca2+ activity, activation of Ca2+ sensitive K+ (GARDOS) channels [Lang et al., 
2003b], K+ exit, hyperpolarization of the erythrocyte membrane potential and Cl- exit 
[Myssina et al., 2004]. The exit of KCl is followed by osmotically obliged water and thus 
leads to cell shrinkage [Lang et al., 1998a]. Chlorpromazine has further been reported to 
induce echinocytic shape [Eskelinen 1987] and cell swelling [Thompson et al., 1993].  
  As shown earlier [Koka et al., 2007a; Koka et al., 2007b], eryptosis is further 
stimulated by P. falciparum infection. Besides its effect on eryptosis, chlorpromazine 
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exerted a remarkable inhibitory effect on in vitro parasitemia. This effect does not correlate 
with the scrambling effect of chlorpromazine and is not paralleled by decreased 
intraerythrocytic survival of the pathogen but may be an effect on parasite internalization. 
Most importantly, chlorpromazine proved to be similarly effective in vivo. Following 
infection with P. berghei the parasitemia decreased significantly in chlorpromazine treated 
mice than in untreated mice.  
  
Decreased in vivo parasitemia following chlorpromazine treatment may be expected 
to affect the survival of infected animals. None of the untreated mice survived the infection 
with P. berghei. In contrast, 80 % of the chlorpromazine treated mice were still alive 30 
days after the infection. Thus chlorpromazine treatment indeed favourably modifies the 
course of malaria.  
  
The protective effect of chlorpromazine is probably not the result of a direct toxic 
action on the pathogen, as chlorpromazine, even at excessive concentrations, did not decrease 
the intracellular DNA/RNA content. Rather chlorpromazine decreases the ability of 
pathogens to invade noninfected erythrocytes leading to a marked decrease of parasitemia. 
Moreover, the scrambling effect of chlorpromazine decreased the life span of infected 
erythrocytes in circulating blood. In conclusion, chlorpromazine triggers eryptosis of infected 
erythrocytes, an effect, which favourably influences the course of malaria.  
 
V.5. Conclusions 
All the observations in our study which include iron deficiency [Koka et al. 2007a], 
treatment with lead [Koka et al. 2007b], chlorpromazine and NO synthase inhibition by   
L-NAME accelerate eryptosis of infected erythrocytes and are thus partially protective 
against malaria. The observations support the view that accelerated suicidal death of 
infected erythrocytes is a host mechanism to counteract infection with the intracellular 
pathogen and open new perspectives for pharmacological treatment of this devastating 
disease. 
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